| Ident. | Authors (with country if any) | Title |
|---|
| 000002 |
Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. |
| 000009 |
Joaquin A. Vizcarra [Pérou] ; Anthony E. Lang [Canada] ; Kapil D. Sethi [États-Unis] ; Alberto J. Espay [États-Unis] | Vascular Parkinsonism: deconstructing a syndrome. |
| 000021 |
Alfonso Fasano [Canada] ; Günther Deuschl [Allemagne] | Therapeutic advances in tremor. |
| 000027 |
A Claudio Cuello [Canada] ; Moussa Youdim | Theodore Lionel Sourkes obituary. |
| 000054 |
Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie] | Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease. |
| 000055 |
Drew S. Kern [Canada] ; Anthony E. Lang [Canada] | Successful treatment of functional palatal tremor: Insights into pathogenesis and management. |
| 000060 |
Xinlu Li [Canada] ; Kalle Gehring [Canada] | Structural studies of parkin and sacsin: Mitochondrial dynamics in neurodegenerative diseases. |
| 000066 |
Antonella Conte [Italie] ; Gina Ferrazzano [Italie] ; Nicoletta Manzo [Italie] ; Giorgio Leodori [Italie] ; Giovanni Fabbrini [Italie] ; Alfonso Fasano [Canada] ; Michele Tinazzi [Italie] ; Alfredo Berardelli [Italie] | Somatosensory temporal discrimination in essential tremor and isolated head and voice tremors. |
| 000089 |
Anosha Zanjani [Canada] ; Konstantine K. Zakzanis [Canada] ; Zafiris J. Daskalakis [Canada] ; Robert Chen [Canada] | Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature. |
| 000095 |
Ronald B. Postuma [Canada] ; Charles H. Adler [États-Unis] ; Brittany N. Dugger [États-Unis] ; Joseph G. Hentz [États-Unis] ; Holly A. Shill [États-Unis] ; Erika Driver-Dunckley [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Sandra A. Jacobson [États-Unis] ; Christine M. Belden [États-Unis] ; Lucia I. Sue [États-Unis] ; Geidy Serrano [États-Unis] ; Thomas G. Beach [États-Unis] | REM sleep behavior disorder and neuropathology in Parkinson's disease. |
| 000124 |
Shady Rahayel [Canada] ; Jacques Montplaisir ; Oury Monchi ; Christophe Bedetti ; Ronald B. Postuma ; Simona Brambati ; Julie Carrier ; Sven Joubert ; Véronique Latreille ; Thomas Jubault ; Jean-François Gagnon | Patterns of cortical thinning in idiopathic rapid eye movement sleep behavior disorder. |
| 000171 |
Helen Ling [Royaume-Uni] ; Yasmine T. Asi [Royaume-Uni] ; Igor N. Petrovic [Royaume-Uni] ; Zeshan Ahmed [Royaume-Uni] ; L K Prashanth [Canada] ; Lili-Naz Hazrati [Canada] ; Masatoyo Nishizawa [Japon] ; Tetsutaro Ozawa [Japon] ; Anthony Lang [Canada] ; Andrew J. Lees [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] | Minimal change multiple system atrophy: an aggressive variant? |
| 000179 |
Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Charles H. Adler [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda Halliday [Australie] ; Lawrence Joseph [Canada] ; Anthony E. Lang [Canada] ; Inga Liepelt-Scarfone [Allemagne] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne] | MDS research criteria for prodromal Parkinson's disease. |
| 000180 |
Ronald B. Postuma [Canada] ; Daniela Berg [Allemagne] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] ; C Warren Olanow [États-Unis] ; Wolfgang Oertel [Allemagne] ; José Obeso [Espagne] ; Kenneth Marek [États-Unis] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; Glenda Halliday [Australie] ; Christopher G. Goetz [États-Unis] ; Thomas Gasser [Allemagne] ; Bruno Dubois [France] ; Piu Chan [République populaire de Chine] ; Bastiaan R. Bloem [Pays-Bas] ; Charles H. Adler [États-Unis] ; Günther Deuschl [Allemagne] | MDS clinical diagnostic criteria for Parkinson's disease. |
| 000204 |
Alfonso Fasano [Canada] ; Louis W C. Liu ; Yu-Yan Poon ; Antony E. Lang | Initiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model. |
| 000205 |
Melissa J. Armstrong [États-Unis] ; Sarah Duff-Canning ; C. Psych [Canada] ; Matthew Kowgier [Canada] ; Connie Marras [Canada] | Independent application of montreal cognitive assessment/mini-mental state examination conversion. |
| 000212 |
Pierre J. Blanchet [Canada] ; Emmanuelle Pourcher | In memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014. |
| 000223 |
Isabelle Beaulieu-Boire [Canada] ; Alfonso Fasano [Canada] | Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term. |
| 000264 |
Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Anthony E. Lang [Canada] | Disease-modifying strategies for Parkinson's disease. |
| 000284 |
Tanya Simuni [États-Unis] ; Chelsea Caspell-Garcia [États-Unis] ; Christopher Coffey [États-Unis] ; Lama M. Chahine [États-Unis] ; Shirley Lasch [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Geert Mayer ; Birgit Högl [Autriche] ; Ron Postuma [Canada] ; Aleksandar Videnovic [États-Unis] ; Amy Willis Amara [États-Unis] ; Ken Marek [États-Unis] | Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. |
| 000304 |
Ronald B. Postuma [Canada] | Can Parkinson's Disease Come From the Gut? |
| 000309 |
Isabelle Beaulieu-Boire [Canada] ; Anthony E. Lang | Behavioral effects of levodopa. |
| 000317 |
Kaviraja Udupa [Canada] ; Ayda Ghahremani [Canada] ; Robert Chen [Canada] | Are we close to the advent of closed loop deep brain stimulation in Parkinson's disease? |
| 000340 |
John C. Steele ; Robert Wresch [États-Unis] ; Samuel D. Hanlon [États-Unis] ; Jay Keystone [Canada] ; Yoav Ben-Shlomo [Royaume-Uni] | A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam. |
| 000351 |
Aaron Sturrock [Canada] ; Corree Laule ; Katy Wyper ; Ruth A. Milner ; Joji Decolongon ; Rachelle Dar Santos ; Allison J. Coleman ; Kimberley Carter ; Susan Creighton ; Natalie Bechtel ; Stefan Bohlen ; Ralf Reilmann ; Hans J. Johnson ; Michael R. Hayden ; Sarah J. Tabrizi ; Alex L. Mackay ; Blair R. Leavitt | A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers. |
| 000369 |
Souha Mahmoudi [Canada] ; Daniel Lévesque ; Pierre J. Blanchet | Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. |
| 000374 |
Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Bastiaan Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda M. Halliday [Australie] ; John Hardy [Royaume-Uni] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne] | Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease |
| 000379 |
Connie Marras [Canada] ; Alexander I. Tröster ; Jaime Kulisevsky ; Glenn T. Stebbins | The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease. |
| 000385 |
Tamara Pringsheim [Canada] ; Nathalie Jette ; Alexandra Frolkis ; Thomas D L. Steeves | The prevalence of Parkinson's disease: a systematic review and meta-analysis. |
| 000401 |
Alfonso Fasano [Canada] ; Andres M. Lozano | The FM/AM world is shaping the future of deep brain stimulation. |
| 000402 |
Connie Marras [Canada] ; Rachel Saunders-Pullman [États-Unis] | The Complexities of Hormonal Influences and Risk of
Parkinson’s Disease |
| 000412 |
Jean-François Daneault [Canada] ; Christian Duval ; Sébastien Barbat-Artigas ; Mylène Aubertin-Leheudre ; Nicolas Jodoin ; Michel Panisset ; Abbas F. Sadikot | Subthalamic stimulation improves motor function but not home and neighborhood mobility. |
| 000413 |
Tiago A. Mestre [Canada] ; Alberto J. Espay ; Connie Marras ; Mark H. Eckman ; Pierre Pollak ; Anthony E. Lang | Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better. |
| 000423 |
Antonio P. Strafella [Canada] ; David Burn | Science to practice: Imaging tools to study cognition in Parkinson's disease. |
| 000432 |
Alfonso Fasano [Canada] ; Andres M. Lozano | Reply: the FM/AM world is shaping the future of deep brain stimulation. |
| 000439 |
Madison T. Gray [Canada] ; Douglas A. Gray ; John M. Woulfe | Reply to: alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. |
| 000441 |
Naomi P. Visanji [Canada] ; Connie Marras ; Louis W C. Liu ; Lili-Naz Hazrati ; Anthony E. Lang | Reply to: Gray et al. |
| 000493 |
Naomi P. Visanji [Canada] | Novel transgenic technology reveals several molecular adaptations and potential therapeutic targets in the direct pathway in levodopa-induced dyskinesia. |
| 000507 |
Emily R. Fisher [Canada] ; Michael R. Hayden | Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. |
| 000546 |
Charlotte Delay [Canada] ; Cyntia Tremblay ; Elodie Brochu ; Sarah Paris-Robidas ; Vincent Emond ; Ali H. Rajput ; Alex Rajput ; Frédéric Calon | Increased LINGO1 in the cerebellum of essential tremor patients. |
| 000581 |
Michael Vesia [Canada] ; Robert Chen | Focal hand dystonia: using brain stimulation to probe network interactions and brain plasticity. |
| 000604 |
Ronald B. Postuma [Canada] | Diagnosing REM sleep behavior disorder in Parkinson's disease-can we avoid the polysomnogram? |
| 000612 |
A Jon Stoessl [Canada] ; Glenda M. Halliday | DAT-SPECT diagnoses dopamine depletion, but not PD. |
| 000638 |
Silke Appel-Cresswell [Canada] ; Ali H. Rajput ; Vesna Sossi ; Christina Thompson ; Vanessa Silva ; Jessamyn Mckenzie ; Katherine Dinelle ; Siobhan E. Mccormick ; Carles Vilari O-Güell ; A Jon Stoessl ; Dennis W. Dickson ; Chris A. Robinson ; Matthew J. Farrer ; Alex Rajput | Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism. |
| 000640 |
Anthony E. Lang [Canada] | Clinical heterogeneity in progressive supranuclear palsy: challenges to diagnosis, pathogenesis and future therapies. |
| 000658 |
Shraddha Sapkota [Canada] ; Myrlene Gee ; Jennifer Sabino ; Derek Emery ; Richard Camicioli | Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease. |
| 000668 |
Madison T. Gray [Canada] ; David G. Munoz ; Douglas A. Gray ; Michael G. Schlossmacher ; John M. Woulfe | Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. |
| 000670 |
Naomi P. Visanji [Canada] ; Connie Marras ; Lili-Naz Hazrati ; Louis W C. Liu ; Anthony E. Lang | Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. |
| 000689 |
Andre C. Felicio [Canada] ; Katherine Dinelle [Canada] ; Pankaj A. Agarwal [Canada] ; Jessamyn Mckenzie [Canada] ; Nicole Heffernan [Canada] ; Jeremy D. Road [Canada] ; Silke Appel-Cresswell [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [Canada] ; Michael Schulzer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada] | In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers |
| 000714 |
Anthony E. Lang [Canada] ; Eldad Melamed ; Werner Poewe [Autriche] ; Olivier Rascol | Trial designs used to study neuroprotective therapy in Parkinson's disease. |
| 000738 |
Andrew B. Singleton [États-Unis] ; Matthew J. Farrer [Canada] ; Vincenzo Bonifati [Pays-Bas] | The genetics of Parkinson’s disease: progress and therapeutic implications |
| 000762 |
Anand I. Rughani [Canada] ; Andres M. Lozano | Surgical treatment of myoclonus dystonia syndrome. |
| 000783 |
Fatemeh Mollaei [Canada] ; Douglas M. Shiller [Canada] ; Vincent L. Gracco [Canada, États-Unis] | Sensorimotor adaptation of speech in Parkinson’s disease |
| 000809 |
Marie-Pierre Fournier-Gosselin [Canada] ; Nir Lipsman ; Jean A. Saint-Cyr ; Clement Hamani ; Andres M. Lozano | Regional anatomy of the pedunculopontine nucleus: relevance for deep brain stimulation. |
| 000819 |
Mateusz Zurowski [Canada] ; William M. Mcdonald [États-Unis] ; Susan Fox [Canada] ; Laura Marsh [États-Unis] | Psychiatric Comorbidities in Dystonia: Emerging Concepts |
| 000827 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon ; Amélie Pelletier ; Jacques Montplaisir | Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies. |
| 000837 |
Michael G. Heckman [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Jan O. Aasly [Norvège] ; Nadine Abahuni [Allemagne] ; Grazia Annesi ; Justin A. Bacon [États-Unis] ; Soraya Bardien [Afrique du Sud] ; Maria Bozi [Grèce] ; Alexis Brice [France] ; Laura Brighina [Italie] ; Jonathan Carr [Afrique du Sud] ; Marie-Christine Chartier-Harlin [France] ; Efthimios Dardiotis [Grèce] ; Dennis W. Dickson [États-Unis] ; Nancy N. Diehl [États-Unis] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Brian Fiske [États-Unis] ; J. Mark Gibson [Irlande (pays)] ; Rachel Gibson [Royaume-Uni] ; Georgios M. Hadjigeorgiou [Grèce] ; Nobutaka Hattori [Japon] ; Faycal Hentati [Tunisie] ; John P. A. Ioannidis [Grèce, États-Unis] ; Magdalena Boczarska-Jedynak [Pologne] ; Barbara Jasinska-Myga [Pologne] ; Beom S. Jeon [Corée du Sud] ; Yun Joong Kim [Corée du Sud] ; Christine Klein [Allemagne] ; Rejko Kruger [Allemagne] ; Elli Kyratzi [Grèce] ; Suzanne Lesage [France] ; Chin-Hsien Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Demetrius M. Maraganore [États-Unis] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Sung Sup Park [Corée du Sud] ; Simona Petrucci [Italie] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Young Ho Sohn [Corée du Sud] ; Leonidas Stefanis [Grèce] ; Vera Tadic [Allemagne] ; Jessie Theuns [Belgique] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Christine Van Broeckhoven [Belgique] ; Simone Van De Loo [Allemagne] ; Demetrios K. Vassilatis [Grèce] ; Carles Vilari O-Güell [Canada] ; Linda R. White [Norvège] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [Belgique] ; Ruey-Meei Wu [Taïwan] ; Matthew J. Farrer [Canada] ; Owen A. Ross [États-Unis] | Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology Of Parkinson’s Disease (GEO-PD) consortium |
| 000843 |
Alberto Albanese [Italie] ; Kailash Bhatia [Royaume-Uni] ; Susan B. Bressman [États-Unis] ; Mahlon R. Delong [États-Unis] ; Stanley Fahn [États-Unis] ; Victor S. C. Fung [Australie] ; Mark Hallett [États-Unis] ; Joseph Jankovic [États-Unis] ; H. A. Jinnah [États-Unis] ; Christine Klein [Allemagne] ; Anthony E. Lang [Canada] ; Jonathan W. Mink [États-Unis] ; Jan K. Teller [États-Unis] | Phenomenology and classification of dystonia: a consensus update |
| 000848 |
Soraya Bardien [Afrique du Sud] ; Janine Blanckenberg [Afrique du Sud] ; Lize Van Der Merwe [Afrique du Sud] ; Matthew J. Farrer [Canada] ; Owen A. Ross [États-Unis] | Patient-Control Association Study of the LRRK2 Gene in South African Parkinson’s Disease Patients |
| 000861 |
Alex A. Macdonald [Canada] ; Oury Monchi ; Ken N. Seergobin ; Hooman Ganjavi ; Ruzbeh Tamjeedi ; Penny A. Macdonald | Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function. |
| 000869 |
Christian Duval [Canada] | Ocular tremor in Parkinson's disease: the debate is not over. |
| 000904 |
Anthony E. Lang [Canada] ; Shirley Eberly ; Christopher G. Goetz ; Glenn Stebbins ; David Oakes ; Ken Marek ; Bernard Ravina ; Caroline M. Tanner ; Ira Shoulson | Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments. |
| 000912 |
Alexandru Hanganu [Canada] ; Christophe Bedetti ; Thomas Jubault ; Jean-Francois Gagnon ; Béatriz Mejia-Constain ; Clotilde Degroot ; Anne-Louise Lafontaine ; Sylvain Chouinard ; Oury Monchi | Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration. |
| 000918 |
Connie Marras [Canada] ; Melissa J. Armstrong [Canada] ; Christopher A. Meaney [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; William Reginold [Canada] ; David F. Tang-Wai [Canada] ; David Gill [États-Unis] ; Paul J. Eslinger [États-Unis] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; Fred J. Marshall [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin L. Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin T. Mast [États-Unis] ; Adam T. Gerstenecker [États-Unis] ; Sandra Weintraub [États-Unis] ; Sarah Duff-Canning [Canada] | Measuring Mild Cognitive Impairment in Patients With Parkinson’s Disease |
| 000957 |
Ludy C. Shih [États-Unis] ; Veronique G. Vanderhorst [États-Unis] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada, France] | Improvement of Pisa syndrome with contralateral pedunculopontine stimulation |
| 000970 |
Siavash Jafari [Canada] ; Mahyar Etminan ; Farhad Aminzadeh ; Ali Samii | Head injury and risk of Parkinson disease: a systematic review and meta-analysis. |
| 000998 |
Andrea Gold [Canada] ; Zorbey T. Turkalp ; David G. Munoz | Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. |
| 000A15 |
Jovana Lubarda [Canada] ; Sarah E. Groleau ; Nancy Thomas ; Mark A. Ferro ; Ram K. Mishra ; Joseph P. Gabriele | Dysregulation of novel catecholamine-regulated protein 40 (CRP40) in Parkinson's disease patients. |
| 000A50 |
Anthony E. Lang [Canada] | Commentary. |
| 000A51 |
Susan Fox [Canada] | Commentary. |
| 000A62 |
Janice C. Wong [Canada] ; Melissa J. Armstrong ; Anthony E. Lang ; Lili-Naz Hazrati | Clinicopathological review of pallidonigroluysian atrophy. |
| 000A64 |
Antoine Duquette [Canada] ; Bernard Brais ; Jean-Pierre Bouchard ; Jean Mathieu | Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay. |
| 000A86 |
Pankaj A. Agarwal [Canada] ; A Jon Stoessl | Biomarkers for trials of neuroprotection in Parkinson's disease. |
| 000A88 |
Christos Sidiropoulos [Canada] ; William Hutchison ; Tiago Mestre ; Elena Moro ; Ian A. Prescott ; Alejandro Valencia Mizrachi ; Melanie Fallis ; Anand I. Rughani ; Suneil K. Kalia ; Andres Lozano ; Susan Fox | Bilateral pallidal stimulation for Wilson's disease. |
| 000B09 |
Silke Appel-Cresswell [Canada] ; Carles Vilarino-Guell ; Mary Encarnacion ; Holly Sherman ; Irene Yu ; Brinda Shah ; David Weir ; Christina Thompson ; Chelsea Szu-Tu ; Joanne Trinh ; Jan O. Aasly ; Alex Rajput ; Ali H. Rajput ; A. Jon Stoessl ; Matthew J. Farrer | Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. |
| 000B24 |
Daniela Buha [Canada] ; Geneviève Bernard ; Toshiyuki Fukao ; Jean-Claude Décarie ; Sylvain Chouinard ; Grant A. Mitchell | A treatable new cause of chorea: beta-ketothiolase deficiency. |
| 000B25 |
Sonia Franciosi [Canada] ; Yaein Shim ; Margaret Lau ; Michael R. Hayden ; Blair R. Leavitt | A systematic review and meta-analysis of clinical variables used in Huntington disease research. |
| 000B52 |
Chenjie Xia [Canada] ; Antoine Duquette ; Steven Frucht ; Anne-Louise Lafontaine | Whipple's disease presenting with segmental myoclonus and hypersomnia. |
| 000B73 |
Thomas D. Steeves [Canada] ; Lundy Day ; Jonathan Dykeman ; Nathalie Jette ; Tamara Pringsheim | The prevalence of primary dystonia: a systematic review and meta-analysis. |
| 000B75 |
William Reginold [Canada] ; Melissa J. Armstrong ; Sarah Duff-Canning ; Anthony Lang ; David Tang-Wai ; Susan Fox ; Brandon Rothberg ; Cindy Zadikoff ; Nancy Kennedy ; David Gill ; Paul Eslinger ; Mark Mapstone ; Kelvin Chou ; Carol Persad ; Irene Litvan ; Benjamin Mast ; Connie Marras | The pill questionnaire in a nondemented Parkinson's disease population. |
| 000B80 |
Tamara Pringsheim [Canada] ; Katie Wiltshire ; Lundy Day ; Jonathan Dykeman ; Thomas Steeves ; Nathalie Jette | The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. |
| 000C43 |
Silvia Rios Romenets [Canada] ; Jean-Francois Gagnon ; Véronique Latreille ; Michel Panniset ; Sylvain Chouinard ; Jacques Montplaisir ; Ronald B. Postuma | Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. |
| 000C44 |
Ronald B. Postuma [Canada] ; Josie-Anne Bertrand ; Jacques Montplaisir ; Catherine Desjardins ; Mélanie Vendette ; Silvia Rios Romenets ; Michel Panisset ; Jean-François Gagnon | Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. |
| 000D21 |
Susan Fox [Canada] | Lost in translation: misfolded proteins may cause neurodegeneration by inhibiting normal protein production. |
| 000D60 |
Ronald B. Postuma [Canada] ; Dag Aarsland ; Paolo Barone ; David J. Burn ; Christopher H. Hawkes ; Wolfgang Oertel ; Tjalf Ziemssen | Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. |
| 000E16 |
Kaylena A Ehgoetz Martens [Canada] ; Quincy J. Almeida | Dissociating between sensory and perceptual deficits in PD: more than simply a motor deficit. |
| 000E34 |
David R. Lynch [États-Unis] ; Massimo Pandolfo [Belgique] ; Jorg B. Schulz [Allemagne] ; Susan Perlman [États-Unis] ; Martin B. Delatycki [Australie] ; R. Mark Payne [États-Unis] ; Robert Shaddy [États-Unis] ; Kenneth H. Fischbeck [États-Unis] ; Jennifer Farmer [États-Unis] ; Paul Kantor [Canada] ; Subha V. Raman [États-Unis] ; Lisa Hunegs [États-Unis] ; Joanne Odenkirchen [États-Unis] ; Kristy Miller [États-Unis] ; Petra Kaufmann [États-Unis] | Common Data Elements for Clinical Research in Friedreich Ataxia |
| 000E42 |
Josie-Anne Bertrand [Canada] ; Christophe Bedetti ; Ronald B. Postuma ; Oury Monchi ; Daphné Génier Marchand ; Thomas Jubault ; Jean-François Gagnon | Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations. |
| 000E47 |
Lili-Naz Hazrati [Canada] ; Janice C. Wong ; Clement Hamani ; Andres M. Lozano ; Yu-Yan Poon ; Jonathan O. Dostrovsky ; William D. Hutchison ; Cindy Zadikoff ; Elena Moro | Clinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation. |
| 000E66 |
Mélanie Vendette [Canada] ; Jacques Montplaisir ; Nadia Gosselin ; Jean-Paul Soucy ; Ronald B. Postuma ; Thien Thanh Dang-Vu ; Jean-François Gagnon | Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment. |
| 000E79 |
M Anne Harris [Canada] ; Joseph K. Tsui ; Stephen A. Marion ; Hui Shen ; Kay Teschke | Association of Parkinson's disease with infections and occupational exposure to possible vectors. |
| 000E99 |
Binit B. Shah [Canada] ; Anthony E. Lang | Acquired neurosyphilis presenting as movement disorders. |
| 000F31 |
CHENJIE XIA [Canada] ; Antoine Duquette [Canada, États-Unis] ; Steven Frucht [États-Unis] ; Anne-Louise Lafontaine [Canada] | Whipple's Disease Presenting with Segmental Myoclonus and Hypersomnia |
| 000F41 |
Bradley Osterman [Canada] ; Michel Sylvain [Canada] ; Sylvain Chouinard [Canada] ; Genevieve Bernard [Canada] | Tremor-Ataxia With Central Hypomyelination (TACH): Dystonia as a New Clinical Feature |
| 000F44 |
Matthew B. Stern [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] | Toward a Redefinition of Parkinson's Disease |
| 000F48 |
Thomas D. Steeves [Canada] ; Lundy Day [Canada] ; Jonathan Dykeman [Canada] ; Nathalie Jette [Canada] ; Tamara Pringsheim [Canada] | The Prevalence of Primary Dystonia: A Systematic Review and Meta-analysis |
| 000F50 |
William Reginold [Canada] ; Melissa J. Armstrong [Canada] ; Sarah Duff-Canning [Canada] ; Anthony Lang [Canada] ; David Tang-Wai [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; David Gill [États-Unis] ; Paul Eslinger [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin Mast [États-Unis] ; Connie Marras [Canada] | The Pill Questionnaire in a Nondemented Parkinson's Disease Population |
| 000F56 |
Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada] | The Neurobiology and Neural Circuitry of Cognitive Changes in Parkinson's Disease Revealed by Functional Neuroimaging |
| 000F57 |
Tamara Pringsheim [Canada] ; Katie Wiltshire [Canada] ; Lundy Day [Canada] ; Jonathan Dykeman [Canada] ; Thomas Steeves [Canada] ; Nathalie Jette [Canada] | The Incidence and Prevalence of Huntington's Disease: A Systematic Review and Meta-analysis |
| 000F65 |
Christian Pifl [Autriche] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] | Thalamic Noradrenaline in Parkinson's Disease: Deficits Suggest Role in Motor and Non-Motor Symptoms |
| 000F70 |
Travis S. Tierney [États-Unis] ; Andres M. Lozano [Canada] | Surgical Treatment for Secondary Dystonia |
| 000F72 |
Valérie Cochen De Cock [France] ; Sophie Bayard [France] ; HUAN YU [France, République populaire de Chine] ; Magda Grini [France] ; Bertrand Carlander [France] ; Ron Postuma [Canada] ; Mahmoud Charif [France] ; Yves Dauvilliers [France] | Suggested Immobilization Test for Diagnosis of Restless Legs Syndrome in Parkinson's Disease |
| 000F79 |
Mark J. Edwards [Royaume-Uni] ; Anthony E. Lang [Canada] ; Kailash P. Bhatia [Royaume-Uni] | Stereotypies: A Critical Appraisal and Suggestion of a Clinically Useful Definition |
| 001006 |
Silvia Rios Romenets [Canada] ; Jean-Francois Gagnon [Canada] ; Véronique Latreille [Canada] ; Michel Panniset [Canada] ; Sylvain Chouinard [Canada] ; Jacques Montplaisir [Canada] ; Ronald B. Postuma [Canada] | Rapid Eye Movement Sleep Behavior Disorder and Subtypes of Parkinson's Disease |
| 001008 |
Ronald B. Postuma [Canada] ; Josie-Anne Bertrand [Canada] ; Jacques Montplaisir [Canada] ; Catherine Desjardins [Canada] ; Mélanie Vendette [Canada] ; Silvia Rios Romenets [Canada] ; Michel Panisset [Canada] ; Jean-François Gagnon [Canada] | Rapid Eye Movement Sleep Behavior Disorder and Risk of Dementia in Parkinson's Disease: A Prospective Study |
| 001013 |
Alfonso Fasano [Italie] ; Anabela Valadas [Portugal, Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; L. K. Prashanth [Canada] ; Anthony E. Lang [Canada] ; Renato P. Munhoz [Brésil] ; Francesca Morgante [Italie] ; Daniel Tarsy [États-Unis] ; Andrew P. Duker [États-Unis] ; Paolo Girlanda [Italie] ; Anna Rita Bentivoglio [Italie] ; Alberto J. Espay [États-Unis] | Psychogenic Facial Movement Disorders: Clinical Features and Associated Conditions |
| 001021 |
Andrew Siderowf [États-Unis] ; Anthony E. Lang [Canada] | Premotor Parkinson's Disease: Concepts and Definitions |
| 001030 |
Andrew Lees (neurologue) [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla M. Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M. Maral Mouradian [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis] | Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease |
| 001054 |
Jana Godau [Allemagne] ; Anna Hussl [Autriche] ; Praween Lolekha [Canada] ; A. Jon Stoessl [Canada] ; Klaus Seppi [Autriche] | Neuroimaging: Current Role in Detecting Pre-Motor Parkinson's Disease |
| 001058 |
Igor N. Petrovic [Royaume-Uni] ; Helen Ling [Royaume-Uni, Serbie] ; Yasmine Asi [Serbie] ; Zeshan Ahmed [Serbie] ; Prashanth L. Kukkle [Canada] ; Lili-Naz Hazrati [Canada] ; Anthony E. Lang [Canada] ; Tamas Revesz [Serbie] ; Janice L. Holton [Serbie] ; Andrew Lees (neurologue) [Royaume-Uni, Serbie] | Multiple System Atrophy- Parkinsonism with Slow Progression and Prolonged Survival: A Diagnostic Catch |
| 001067 |
Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France] | Long-Term Outcomes of Surgical Therapies for Parkinson's Disease |
| 001069 |
Aron S. Buchman [États-Unis] ; Sukriti Nag [États-Unis] ; Joshua M. Shulman [États-Unis] ; Andrew S. P. Lim [Canada] ; Veronique G. J. M. Vanderhorst [États-Unis] ; Sue E. Leurgans [États-Unis] ; Julie A. Schneider [États-Unis] ; David A. Bennett [États-Unis] | Locus Coeruleus Neuron Density and Parkinsonism in Older Adults Without Parkinson's Disease |
| 001094 |
Pankaj Agarwal [Canada] ; Penelope Hogarth [États-Unis] ; Susan Hayflick [États-Unis] ; Patrick Macleod [Canada] ; Renju Kuriakose [Canada] ; Jessamyn Mckenzie [Canada] ; Nicole Heffernan [Canada] ; Katie Dinelle [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada] | Imaging Striatal Dopaminergic Function in Phospholipase A2 Group VI-Related Parkinsonism |
| 001097 |
Ronald B. Postuma [Canada] ; Dag Aarsland [Norvège] ; Paolo Barone [Italie] ; David J. Burn [Royaume-Uni] ; Christopher H. Hawkes [Royaume-Uni] ; Wolfgang Oertel [Allemagne] ; Tjalf Ziemssen [Allemagne] | Identifying Prodromal Parkinson's Disease: Pre-Motor Disorders in Parkinson's Disease |
| 001110 |
Samuel M. Goldman [États-Unis] ; Freya Kamel [États-Unis] ; G. Webster Ross [États-Unis] ; Grace S. Bhudhikanok [États-Unis] ; Jane A. Hoppin [États-Unis] ; Monica Korell [États-Unis] ; Connie Marras [Canada] ; Cheryl Meng [États-Unis] ; David M. Umbach [États-Unis] ; Meike Kasten [Allemagne] ; Anabel R. Chade [Argentine] ; Kathleen Comyns [États-Unis] ; Marie B. Richards [États-Unis] ; Dale P. Sandler [États-Unis] ; Aaron Blair [États-Unis] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis] | Genetic Modification of the Association of Paraquat and Parkinson's Disease |
| 001140 |
Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis] | Dopamine Transporter Imaging Is Associated With Long-Term Outcomes in Parkinson's Disease |
| 001143 |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study |
| 001144 |
Kaylena A. Ehgoetz Martens [Canada] ; Quincy J. Almeida [Canada] | Dissociating Between Sensory and Perceptual Deficits in PD: More Than Simply a Motor Deficit |
| 001164 |
Josie-Anne Bertrand [Canada] ; Christophe Bedetti [Canada] ; Ronald B. Postuma [Canada] ; Oury Monchi [Canada] ; Daphne Génier Marchand [Canada] ; Thomas Jubault [Canada] ; Jean-François Gagnon [Canada] | Color Discrimination Deficits in Parkinson's Disease are Related to Cognitive Impairment and White-Matter Alterations |
| 001166 |
Lili-Naz Hazrati [Canada] ; Janice C. Wong [Canada] ; Clement Hamani [Canada] ; Andres M. Lozano [Canada] ; Yu-Yan Poon [Canada] ; Jonathan O. Dostrovsky [Canada] ; William D. Hutchison [Canada] ; Cindy Zadikoff [Canada, États-Unis] ; Elena Moro [Canada] | Clinicopathological Study in Progressive Supranuclear Palsy With Pedunculopontine Stimulation |
| 001186 |
Mélanie Vendette [Canada] ; Jacques Montplaisir [Canada] ; Nadia Gosselin [Canada] ; Jean-Paul Soucy [Canada] ; Ronald B. Postuma [Canada] ; Thien Thanh Dang-Vu [Canada, Belgique] ; Jean-François Gagnon [Canada] | Brain Perfusion Anomalies in Rapid Eye Movement Sleep Behavior Disorder with Mild Cognitive Impairment |
| 001203 |
M. Anne Harris [Canada] ; Joseph K. Tsui [Canada] ; Stephen A. Marion [Canada] ; HUI SHEN [Canada] ; Kay Teschke [Canada] | Association of Parkinson's Disease With Infections and Occupational Exposure to Possible Vectors |
| 001220 |
Binit B. Shah [Canada] ; Anthony E. Lang [Canada] | Acquired Neurosyphilis Presenting as Movement Disorders |
| 001226 |
Ronald B. Postuma [Canada] ; Isabelle Arnulf [France] ; Birgit Hogl [Autriche] ; Alex Iranzo [Espagne] ; Tomoyuki Miyamoto [Japon] ; Yves Dauvilliers [France] ; Wolfgang Oertel [Allemagne] ; Yo-Ei Ju [États-Unis] ; Monica Puligheddu [Italie] ; Poul Jennum [Danemark] ; Amelie Pelletier [Canada] ; Christina Wolfson [Canada] ; Smaranda Leu-Semenescu [France] ; Birgit Frauscher [Autriche] ; Masayuki Miyamoto [Japon] ; Valerie Cochen De Cock [France] ; Marcus M. Unger [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Maria Livia Fantini [Italie] ; Jacques Y. Montplaisir [Canada] | A Single-Question Screen for Rapid Eye Movement Sleep Behavior Disorder: A Multicenter Validation Study |
| 001234 |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A Multicenter Randomized Placebo-Controlled Clinical Trial of Pramipexole for Tourette's Syndrome |
| 001238 |
Binit B. Shah [Canada] ; Anthony E. Lang [Canada] | A Case of Neurosyphilis Presenting with Myoclonus, Cerebellar Ataxia, and Speech Disturbance |
| 001256 |
Richard Camicioli [Canada] | Metabotropic glutamate receptors—mGluR5—new kid on the dissecting block? |
| 001283 |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia |
| 001298 |
Kathleen E. Norman [Canada] ; Shauna N. D'Amboise [Canada] ; Giovanna Pari [Canada] ; Martin E. Héroux [Canada] | Tremor during movement correlates well with disability in people with essential tremor |
| 001305 |
Pascal H. H. M. Van Lieshout [Canada] ; Catriona M. Steele [Canada] ; Anthony E. Lang [Canada] | Tongue control for swallowing in Parkinson's disease: Effects of age, rate, and stimulus consistency |
| 001308 |
Nicola Z. Hobbs [Royaume-Uni] ; Amy V. Pedrick [Royaume-Uni] ; Miranda J. Say [Royaume-Uni] ; Chris Frost [Royaume-Uni] ; Rachelle Dar Santos [Canada] ; Allison Coleman [Canada] ; Aaron Sturrock [Canada] ; David Craufurd [Royaume-Uni] ; Julie C. Stout [Australie] ; Blair R. Leavitt [Canada] ; Josephine Barnes [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] ; Rachael I. Scahill [Royaume-Uni] | The structural involvement of the cingulate cortex in premanifest and early Huntington's disease |
| 001323 |
Francisco A. Ponce [États-Unis] ; Andres M. Lozano [Canada] | The most cited works in Parkinson's disease |
| 001324 |
Dustin A. Heldman [États-Unis] ; Joseph P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; Sang Jin Kim [Canada] ; Fredy J. Revilla [États-Unis] ; Alberto J. Espay [États-Unis] | The modified bradykinesia rating scale for Parkinson's disease: Reliability and comparison with kinematic measures |
| 001334 |
Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | The curious case of phenocopies in families with genetic Parkinson's disease |
| 001344 |
Andres M. Lozano [Canada] | The Wilson films — Hemiballism |
| 001354 |
Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis] | Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia |
| 001363 |
Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease |
| 001377 |
Philip A. Starr [États-Unis] ; Paul Bejjani [Liban] ; Andres M. Lozano [Canada] ; Leo Verhagen Metman [États-Unis] ; And Marwan I. Hariz [Royaume-Uni] | Stereotactic techniques and perioperative management of DBS in dystonia |
| 001388 |
Diego Santos-García [Espagne] ; Mercedes Macías [Espagne] ; Miguel Llaneza [Canada] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernández [Canada] | Serum vitamin B12 and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion |
| 001399 |
Jonathan Kimmelman [Canada] ; Katherine Duckworth [Canada] ; Tim Ramsay [Canada] ; Tiffini Voss [États-Unis] ; Bernard Ravina [États-Unis] ; Marina Elena Emborg [États-Unis] | Risk of surgical delivery to deep nuclei: A meta‐analysis |
| 001410 |
I. In Yeh [Canada] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada] | Reply: Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated? |
| 001419 |
Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis] | Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long‐term clinical trials |
| 001439 |
Jennifer G. Goldman [États-Unis] ; Darcy Marr [Canada] ; Lili Zhou [États-Unis] ; Bichun Ouyang [États-Unis] ; Sue E. Leurgans [États-Unis] ; Elizabeth Berry-Kravis [États-Unis] ; Christopher G. Goetz [États-Unis] | Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations |
| 001447 |
Anthony E. Lang [Canada] ; Valerie Voon [Royaume-Uni] | Psychogenic movement disorders: Past developments, current status, and future directions |
| 001456 |
Stéphane Thobois [France] ; Takaomi Taira [Japon] ; Cynthia Comella [États-Unis] ; Elena Moro [Canada] ; Susan Bressman [États-Unis] ; And Alberto Albanese [Italie] | Pre‐operative evaluations for DBS in dystonia |
| 001459 |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 001473 |
Roberto Cilia [Canada, Italie] ; Sang Soo Cho [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; Ji Hyun Ko [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada] | Pathological gambling in patients with Parkinson's disease is associated with fronto‐striatal disconnection: A path modeling analysis |
| 001491 |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 001521 |
Marjan Jahanshahi [Royaume-Uni] ; Virginie Czernecki [France] ; And Mateusz Zurowski [Canada] | Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia |
| 001552 |
A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis] | Milestones in neuroimaging |
| 001562 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 001567 |
Richard Camicioli [Canada] | Metabotropic glutamate receptors—mGluR5—new kid on the dissecting block? |
| 001620 |
Helen Bronte-Stewart [États-Unis] ; Takaomi Taira [Japon] ; Francesc Valldeoriola [Espagne] ; Marcello Merello [Argentine] ; William J. Marks Jr. [États-Unis] ; Alberto Albanese [Italie] ; Susan Bressman [États-Unis] ; And Elena Moro [Canada] | Inclusion and exclusion criteria for DBS in dystonia |
| 001628 |
Richard Camicioli [Canada] | If amyloid is not in the spinal fluid in Parkinson's disease, where is it and what does it do? |
| 001643 |
Elena Moro [Canada] ; Alberto Albanese [Italie] ; Joachim K. Krauss [Allemagne] ; Leo Verhagen Metman [États-Unis] ; Marie Vidailhet [France] ; Marwan I. Hariz [Royaume-Uni] | Guest Editors' introduction |
| 001649 |
Owen A. Ross [États-Unis] ; Karen N. Conneely [États-Unis] ; Tao Wang [États-Unis] ; Carles Vilarino-Guell [États-Unis, Canada] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Alex Rajput [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Ryan J. Uitti [États-Unis] ; Elan D. Louis [États-Unis] ; Lorraine N. Clark [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] ; Claudia M. Testa [États-Unis] | Genetic variants of α‐synuclein are not associated with essential tremor |
| 001668 |
Melissa J. Armstrong [Canada] ; Binit B. Shah [Canada] ; Robert Chen [Canada] ; Michael J. Angel [Canada] ; Anthony E. Lang [Canada] | Expanding the phenomenology of benign hereditary chorea: Evolution from chorea to myoclonus and dystonia |
| 001684 |
Richard A. Walsh [Canada] ; Anthony E. Lang [Canada] | Early‐onset tardive dyskinesia in a neuroleptic‐naive patient exposed to low‐dose quetiapine |
| 001686 |
Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim K. Krauss [Allemagne] | Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting |
| 001704 |
Alberto J. Espay [États-Unis] ; Joe P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Emily Dunn [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; Sang Jin Kim [Canada] ; Fredy J. Revilla [États-Unis] ; Dustin A. Heldman [États-Unis] | Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease |
| 001715 |
Anthony E. Lang [Canada] | Deep brain stimulation for dystonia |
| 001725 |
Victor Peralta [Espagne] ; Anthony E. Lang [Canada] | Crossing the borders between neurology and psychiatry in functional neurological disorders |
| 001762 |
Ronald B. Postuma [Canada] ; Jacques Montplaisir [Canada] ; Paola Lanfranchi [Canada] ; Hélène Blais [Canada] ; Sylvie Rompré [Canada] ; Roberto Colombo [Italie] ; Jean-François Gagnon [Canada] | Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder |
| 001764 |
Hrishikesh Kumar [Canada] ; Angela South [Canada] ; Mandar Jog [Canada] | Carbamazepine responsive dysphagia—A variant of paroxysmal kinesigenic dyskinesia? |
| 001770 |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
| 001777 |
Mélanie Vendette [Canada] ; Jean-François Gagnon [Canada] ; Jean-Paul Soucy [Canada] ; Nadia Gosselin [Canada] ; Ronald B. Postuma [Canada] ; Maria Tuineag [Canada] ; Isabelle Godin [Canada] ; Jacques Montplaisir [Canada] | Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder |
| 001800 |
Hongliu Ding [États-Unis] ; Alison K. Sarokhan [États-Unis] ; Sarah S. Roderick [États-Unis] ; Rachit Bakshi [États-Unis] ; Nancy E. Maher [États-Unis] ; Paymon Ashourian [États-Unis] ; Caroline G. Kan [États-Unis] ; Sunny Chang [États-Unis] ; Andrea Santarlasci [États-Unis] ; Kyleen E. Swords [États-Unis] ; Bernard M. Ravina [États-Unis] ; Michael T. Hayes [États-Unis] ; U. Shivraj Sohur [États-Unis] ; Anne-Marie Wills [États-Unis] ; Alice W. Flaherty [États-Unis] ; Vivek K. Unni [États-Unis] ; Albert Y. Hung [États-Unis] ; Dennis J. Selkoe [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Michael G. Schlossmacher [Canada] ; Lewis R. Sudarsky [États-Unis] ; John H. Growdon [États-Unis] ; Adrian J. Ivinson [États-Unis] ; Bradley T. Hyman [États-Unis] ; Clemens R. Scherzer [États-Unis] | Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study |
| 001811 |
Anthony L. Vaccarino [Canada] ; Karen Anderson [États-Unis] ; Beth Borowsky [États-Unis] ; Kevin Duff [États-Unis] ; Joseph Giuliano [États-Unis] ; Mark Guttman [Canada] ; Aileen K. Ho [Royaume-Uni] ; Michael Orth [Allemagne] ; Jane S. Paulsen [États-Unis] ; Terrence Sills [Canada] ; Daniel P. Van Kammen [États-Unis] ; Kenneth R. Evans [Canada] | An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers |
| 001828 |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 001840 |
Mark G. Carpenter [Canada] ; Bastiaan R. Bloem [Pays-Bas] | A new twist on turning movements in Parkinson's disease patients |
| 001846 |
Anthony E. Lang [Canada] | A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials |
| 001866 |
Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada] | Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion |
| 001881 |
Helen Bronte-Stewart [États-Unis] ; Takaomi Taira [Japon] ; Francesc Valldeoriola [Espagne] ; Marcello Merello [Argentine] ; William J. Jr Marks [États-Unis] ; Alberto Albanese [Italie] ; Susan Bressman [États-Unis] ; Elena Moro [Canada] | Inclusion and Exclusion Criteria for DBS in Dystonia |
| 001899 |
HONGLIU DING [États-Unis] ; Alison K. Sarokhan [États-Unis] ; Sarah S. Roderick [États-Unis] ; Rachit Bakshi [États-Unis] ; Nancy E. Maher [États-Unis] ; Paymon Ashourian [États-Unis] ; Caroline G. Kan [États-Unis] ; Sunny Chang [États-Unis] ; Andrea Santarlasci [États-Unis] ; Kyleen E. Swords [États-Unis] ; Bernard M. Ravina [États-Unis] ; Michael T. Hayes [États-Unis] ; U. Shivraj Sohur [États-Unis] ; Anne-Marie Wills [États-Unis] ; Alice W. F. Laherty [États-Unis] ; Vivek K. Unni [États-Unis] ; Albert Y. H. Ung [États-Unis] ; Dennis J. Selkoe [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Michael G. Schlossmacher [Canada] ; Lewis R. Sudarsky [États-Unis] ; John H. Growdon [États-Unis] ; Adrian J. Ivinson [États-Unis] ; Bradley T. Hyman [États-Unis] ; Clemens R. Scherzer [États-Unis] | Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study |
| 001946 |
Michel C. F. Shamy [Canada] | The treatment of psychogenic movement disorders with suggestion is ethically justified |
| 001955 |
Shen-Yang Lim [Canada, Malaisie] ; Anthony E. Lang [Canada] | The nonmotor symptoms of Parkinson's disease—An overview |
| 001960 |
Tiago Mestre [Portugal] ; Anthony E. Lang [Canada] | The grasp reflex: A symptom in need of treatment |
| 001973 |
Jean-François Gagnon [Canada] ; Ronald B. Postuma [Canada] ; Steve Joncas [Canada] ; Catherine Desjardins [Canada] ; Véronique Latreille [Canada] | The Montreal Cognitive Assessment: A screening tool for mild cognitive impairment in REM sleep behavior disorder |
| 001978 |
Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations |
| 001991 |
Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada] | Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) |
| 001A01 |
I-Jin Yeh [Canada, Taïwan] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada] | Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region |
| 001A18 |
A. Jon Stoessl [Canada] | Scans without evidence of dopamine deficiency: The triumph of careful clinical assessment |
| 001A49 |
Cory Toth [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada] | Reply: Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view |
| 001A53 |
Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis] | Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease |
| 001A56 |
Robert Chen [Canada] | Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson's disease |
| 001A58 |
Jason K. Wasserman [Canada] ; Carolina Jimenez-Rivera [Canada] ; Asif Doja [Canada] | Refractory head movements secondary to Sandifer syndrome treated with enteral feeding |
| 001B01 |
Jacques Montplaisir [Canada] ; Jean-Francois Gagnon [Canada] ; Maria Livia Fantini [Italie] ; Ronald B. Postuma [Canada] ; Yves Dauvilliers [France] ; Alex Desautels [Canada] ; Sylvie Rompré [Canada] ; Jean Paquet [Canada] | Polysomnographic diagnosis of idiopathic REM sleep behavior disorder |
| 001B12 |
Douglas E. Hobson [Canada] | Paroxysmal kinesigenic dyskinesia sans dyskinesia or paroxysmal kinesigenic dysesthesia? |
| 001B30 |
Kerrie Schoffer [Canada] | Painful leg moving toes treated with botulinum toxin type A: A video report |
| 001B40 |
Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | Olfactory heterogeneity in LRRK2 related Parkinsonism |
| 001B56 |
Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song Lu | Neuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia |
| 001B76 |
Ali H. Rajput [Canada] ; Ryan J. Uitti [États-Unis] ; Alex Rajput [Canada] ; Kenneth P. Offord [États-Unis] | Mortality in Parkinson's disease |
| 001B85 |
Markus Naumann [Allemagne] ; Alastair Carruthers [Canada] ; Jean Carruthers [Canada] ; Sheena K. Aurora [États-Unis] ; Ross Zafonte [États-Unis] ; Susan Abu-Shakra [États-Unis] ; Terry Boodhoo [États-Unis] ; Mary Ann Miller-Messana [États-Unis] ; George Demos [États-Unis] ; Lynn James [États-Unis] ; Frederick Beddingfield [États-Unis] ; Amanda Vandenburgh [États-Unis] ; Mary Ann Chapman [États-Unis] ; Mitchell F. Brin [États-Unis] | Meta‐analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications |
| 001B96 |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
| 001B99 |
Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] | Long‐term effect of unilateral pallidotomy on levodopa‐induced dyskinesia |
| 001C31 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders |
| 001C40 |
Rodger J. Elble [États-Unis] ; Oksana Suchowersky [Canada] ; Stephanie Shaftman [Canada, États-Unis] ; William J. Weiner [États-Unis] ; Peng Huang [États-Unis] ; Barbara Tilley [États-Unis] | Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease |
| 001C94 |
Simon Zhornitsky [Canada] ; Emmanuel Stip [Canada] ; Tania Pampoulova [Canada] ; Élie Rizkallah [Canada] ; Olivier Lipp [Canada] ; Lahcen Aït Bentaleb [Canada] ; Jean-Pierre Chiasson [Canada] ; Stéphane Potvin [Canada] | Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia |
| 001C96 |
Ruksana Azhu Valappil [États-Unis] ; Jed E. Black [États-Unis] ; Meredith J. Broderick [États-Unis] ; Oscar Carrillo [États-Unis] ; Eric Frenette [Canada] ; Shannon S. Sullivan [États-Unis] ; Samuel M. Goldman [États-Unis] ; Caroline M. Tanner [États-Unis] ; James W. Langston [États-Unis] | Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease |
| 001D21 |
Alberto J. Espay [États-Unis] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Effect of movement frequency on repetitive finger movements in patients with Parkinson's disease |
| 001D24 |
Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis] | Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis |
| 001D30 |
Amitabh Gupta [Canada] ; Anthony E. Lang [Canada] | Drug‐induced cranial myoclonus |
| 001D33 |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 001D35 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada] | Dopamine turnover increases in asymptomatic LRRK2 mutations carriers |
| 001D58 |
Terence D. Sanger [États-Unis] ; Daofen Chen [États-Unis] ; Darcy L. Fehlings [Canada] ; Mark Hallett [États-Unis] ; Anthony E. Lang [Canada] ; Jonathan W. Mink [États-Unis] ; Harvey S. Singer [États-Unis] ; Katharine Alter [États-Unis] ; Hilla Ben-Pazi [Israël] ; Erin E. Butler [États-Unis] ; Robert Chen [Canada] ; Abigail Collins [États-Unis] ; Sudarshan Dayanidhi [États-Unis] ; Hans Forssberg [Suède] ; Eileen Fowler [États-Unis] ; Donald L. Gilbert [États-Unis] ; Sharon L. Gorman [États-Unis] ; Mark E. Gormley Jr. [États-Unis] ; H. A. Jinnah [États-Unis] ; Barbara Kornblau [États-Unis] ; Kristin J. Krosschell [États-Unis] ; Rebecca K. Lehman [États-Unis] ; Colum Mackinnon [États-Unis] ; C. J. Malanga [États-Unis] ; Ronit Mesterman [Canada] ; Margaret Barry Michaels [États-Unis] ; Toni S. Pearson [États-Unis] ; Jessica Rose [États-Unis] ; Barry S. Russman [États-Unis] ; Dagmar Sternad [États-Unis] ; Kathy J. Swoboda [États-Unis] ; Francisco Valero-Cuevas [États-Unis] | Definition and classification of hyperkinetic movements in childhood |
| 001D73 |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
| 001D98 |
Geneviève Bernard [Canada] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Sylvain Chouinard [Canada] | Chylomicron retention disease: Dystonia as a new clinical feature |
| 001E05 |
Susanne A. Schneider [Royaume-Uni, Allemagne] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] ; Benedikt Bader [Allemagne] ; Adrian Danek [Allemagne] ; Kailash P. Bhatia [Royaume-Uni] | Characteristic head drops and axial extension in advanced chorea‐acanthocytosis |
| 001E16 |
Ronald B. Postuma [Canada] ; Paola A. Lanfranchi [Canada] ; Helene Blais [Canada] ; Jean-Francois Gagnon [Canada] ; Jacques Y. Montplaisir [Canada] | Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder |
| 001E18 |
Steven R. Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony E. Lang [Canada] ; Ira Shoulson [États-Unis] | Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease |
| 001E33 |
Andres M. Lozano [Canada] ; Brian J. Snyder [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] | Basal ganglia physiology and deep brain stimulation |
| 001E39 |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Daniel Lévesque [Canada] ; Thérèse Di Paolo [Canada] | BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys |
| 001E53 |
Kaitlyn P. Roland [Canada] ; Mary E. Jenkins [Canada] ; Andrew M. Johnson [Canada] | An exploration of the burden experienced by spousal caregivers of individuals with Parkinson's disease |
| 001E66 |
Manon Bouchard [Canada] ; Sylvain Chouinard [Canada] ; And Oksana Suchowersky [Canada] | Adult cases of congenital muscular torticollis successfully treated with botulinum toxin |
| 001E79 |
Kelvin L. Chou [États-Unis] ; Melissa M. Amick [États-Unis] ; Jason Brandt [États-Unis] ; Richard Camicioli [Canada] ; Karen Frei [États-Unis] ; Darren Gitelman [États-Unis] ; Jennifer Goldman [États-Unis] ; John Growdon [États-Unis] ; Howard I. Hurtig [États-Unis] ; Bonnie Levin [États-Unis] ; Irene Litvan [États-Unis] ; Laura Marsh [États-Unis] ; Tanya Simuni [États-Unis] ; Alexander I. Tröster [États-Unis] ; Ergun Y. Uc [États-Unis] | A recommended scale for cognitive screening in clinical trials of Parkinson's disease |
| 001E80 |
Michael D. Sage [Canada] ; Quincy J. Almeida [Canada] | A positive influence of vision on motor symptoms during sensory attention focused exercise for Parkinson's disease |
| 001E93 |
Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni] | A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy |
| 001F27 |
Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | Olfactory Heterogeneity in LRRK2 Related Parkinsonism |
| 001F36 |
Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] | Long-Term Effect of Unilateral Pallidotomy on Levodopa-Induced Dyskinesia |
| 001F51 |
Simon Zhomitsky [Canada] ; Emmanuel Stip [Canada] ; Tania Pampoulova [Canada] ; Elie Rizkallah [Canada] ; Olivier Lipp [Canada] ; Lahcen Aït Bentaleb [Canada] ; Jean-Pierre Chiasson [Canada] ; Stéphane Potvin [Canada] | Extrapyramidal Symptoms in Substance Abusers with and Without Schizophrenia and in Nonabusing Patients with Schizophrenia |
| 001F52 |
RUKSANA AZHU VALAPPIL [États-Unis] ; Jed E. Black [États-Unis] ; Meredith J. Broderick [États-Unis] ; Oscar Carrillo [États-Unis] ; Eric Frenette [Canada] ; Shannon S. Sullivan [États-Unis] ; Samuel M. Goldman [États-Unis] ; Caroline M. Tanner [États-Unis] ; James W. Langston [États-Unis] | Exploring the Electrocardiogram as a Potential Tool to Screen for Premotor Parkinson's Disease |
| 001F77 |
Daniel Weintraub [États-Unis] ; Staci Hoops [États-Unis] ; Judy A. Shea [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Erika D. Driver-Dunckley [États-Unis] ; Charles H. Adler [États-Unis] ; Marc N. Potenza [États-Unis] ; Janis Miyasaki [Canada] ; Andrew D. Siderowf [États-Unis] ; John E. Duda [États-Unis] ; Howard I. Hurtig [États-Unis] ; Amy Colcher [États-Unis] ; Stacy S. Horn [États-Unis] ; Matthew B. Stern [États-Unis] ; Valerie Voon [États-Unis] | Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease |
| 001F99 |
Renato P. Munhoz [Brésil] ; Helio A. Teive [Brésil] ; Alexandre N. Francisco [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] | Unilateral pallidotomy in a patient with parkinsonism and G2019S LRRK2 mutation |
| 002015 |
Elan D. Louis [États-Unis] ; Phyllis L. Faust [États-Unis] ; Jean-Paul G. Vonsattel [États-Unis] ; Lawrence S. Honig [États-Unis] ; Alex Rajput [Canada] ; Ali Rajput [Canada] ; Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Webster G. Ross [États-Unis] ; Rodger J. Elble [États-Unis] ; Cordelia Erickson-Davis [États-Unis] ; Carol B. Moskowitz [États-Unis] ; Arlene Lawton [États-Unis] | Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains |
| 002026 |
Bernard Ravina [États-Unis] ; Jordan Elm [États-Unis] ; Richard Camicioli [Canada] ; Peter G. Como [États-Unis] ; Laura Marsh [États-Unis] ; Joseph Jankovic [États-Unis] ; Daniel Weintraub [États-Unis] | The course of depressive symptoms in early Parkinson's disease |
| 002035 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Richard Camicioli [Canada] | Temporal lobe changes in early, untreated Parkinson's disease |
| 002040 |
Michael D. Sage [Canada] ; Quincy J. Almeida [Canada] | Symptom and gait changes after sensory attention focused exercise vs aerobic training in Parkinson's disease |
| 002096 |
Rosalind S. Chuang [Canada] ; Anthony E. Lang [Canada] | Rasagiline‐induced spontaneous ejaculation |
| 002167 |
Alberto J. Espay [États-Unis] ; Linda M. Goldenhar [États-Unis] ; Valerie Voon [États-Unis] ; Anette Schrag [Royaume-Uni] ; Noël Burton [États-Unis] ; Anthony E. Lang [Canada] | Opinions and clinical practices related to diagnosing and managing patients with psychogenic movement disorders: An international survey of movement disorder society members |
| 002196 |
Anthony E. Lang [Canada] ; Michael Angel [Canada] ; Kailash Bhatia [Royaume-Uni] ; Robert Chen [Canada] ; Stanley Fahn [États-Unis] ; Mark Hallett [États-Unis] ; Anette Schrag [Royaume-Uni] ; Philip Thompson [Australie] | Myoclonus in complex regional pain syndrome |
| 002219 |
Bart F. L. Van Nuenen [Pays-Bas, Allemagne] ; Thilo Van Eimeren [Canada] ; Joyce P. M. Van Der Vegt [Pays-Bas, Allemagne] ; Carsten Buhmann [Allemagne] ; Christine Klein [Allemagne] ; Bastiaan R. Bloem [Pays-Bas] ; Hartwig R. Siebner [Allemagne, Danemark] | Mapping preclinical compensation in Parkinson's disease: An imaging genomics approach |
| 002226 |
Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France] | Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease |
| 002237 |
Jonathan Kimmelman [Canada, États-Unis] ; Alex John London [États-Unis] ; Bernard Ravina [États-Unis] ; Tim Ramsay [Canada] ; Mark Bernstein [Canada] ; Alan Fine [Canada] ; Frank W. Stahnisch [Canada] ; Marina Elena Emborg [États-Unis] | Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations |
| 002257 |
Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and compulsive behaviors in Parkinson's disease |
| 002260 |
Alberto J. Espay [Canada, États-Unis] ; Dorcas E. Beaton [Canada] ; Francesca Morgante [Canada, Italie] ; Carolyn A. Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study |
| 002264 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Jacques Y. Montplaisir [Canada] | Idiopathic REM sleep behavior disorder in the transition to degenerative disease |
| 002274 |
Richard M. Camicioli ; Thomas P. Bouchard ; Martin J. Somerville [Canada] | Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients |
| 002277 |
Christine Klein [Allemagne, Canada] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Anthony E. Lang [Canada] | Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond |
| 002298 |
Stephanie A. Cobb [États-Unis] ; Christian Wider [États-Unis] ; Owen A. Ross [États-Unis] ; Ignacio F. Mata [États-Unis] ; Charles H. Adler [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Ruey-Meei Wu [Taïwan] ; Robert Hauser [États-Unis] ; Keith A. Josephs [États-Unis] ; Jonathan Carr [Afrique du Sud] ; Katrina Gwinn [États-Unis] ; Michael G. Heckman [États-Unis] ; Jan O. Aasly [Norvège] ; Timothy Lynch [Irlande (pays)] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Gregory Kapatos [États-Unis] ; Matthew J. Farrer [États-Unis] | GCH1 in early‐onset Parkinson's disease |
| 002308 |
Christian Wider [États-Unis] ; Justus C. Dachsel [États-Unis] ; Alexandra I. Soto [États-Unis] ; Michael G. Heckman [États-Unis] ; Nancy N. Diehl [États-Unis] ; Mei Yue [États-Unis] ; Sarah Lincoln [États-Unis] ; Jan O. Aasly [Norvège] ; Kristoffer Haugarvoll [États-Unis, Norvège] ; John Q. Trojanowski [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Deborah Mash [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; J. Mark Gibson [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Dennis W. Dickson [États-Unis] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [États-Unis] ; Owen A. Ross [États-Unis] | FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression |
| 002330 |
Behzad Elahi [Canada] ; Behrad Elahi [Iran] ; Robert Chen [Canada] | Effect of transcranial magnetic stimulation on Parkinson motor function—Systematic review of controlled clinical trials |
| 002342 |
Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse] | Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease |
| 002386 |
Leslie W. Ferguson [Canada] ; Michele L. Rajput [Canada] ; Alexander Rajput [Canada] | Comment on “Individualized Assessment of Quality of Life in Idiopathic Parkinson's Disease” |
| 002395 |
Shen-Yang Lim [Malaisie] ; Pettarusp Wadia [Canada] ; Gregor K. Wenning [Autriche] ; Anthony E. Lang [Canada] | Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2 |
| 002398 |
C. Warren Olanow [États-Unis] ; Jean-Michel Gracies [États-Unis] ; Christopher G. Goetz [États-Unis] ; A. Jon Stoessl [Canada] ; Thomas Freeman [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; James Godbold [États-Unis] ; Jose A. Obeso [Espagne] | Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysis |
| 002406 |
Eppie M. Yiu [Canada] ; Sandra A. Farrell [Canada] ; Teesta Soman [Canada] | Classic Pelizaeus‐Merzbacher disease in a girl with an unbalanced chromosomal translocation and functional duplication of PLP1 |
| 002425 |
Neema Kasravi [Canada] ; Mandar S. Jog [Canada] | Botulinum toxin in the treatment of lingual movement disorders |
| 002429 |
Mandar Jog [Canada] ; Hrishikesh Kumar [Canada] | Bilateral pallidal deep brain stimulation in a case of myoclonus dystonia syndrome |
| 002430 |
Fraser G. A. Moore [Canada] | Bilateral hemichorea–hemiballism caused by metastatic lung cancer |
| 002439 |
Anastasia Levchenko [Canada] ; Jacques-Yves Montplaisir [Canada] ; Géraldine Asselin [Canada] ; Sylvie Provost [Canada] ; Simon L. Girard [Canada] ; Lan Xiong [Canada] ; Emmanuelle Lemyre [Canada] ; Judith St-Onge [Canada] ; Pascale Thibodeau [Canada] ; Alex Desautels [Canada] ; Gustavo Turecki [Canada] ; Claudia Gaspar [Canada] ; Marie-Pierre Dubé [Canada] ; Guy A. Rouleau [Canada] | Autosomal‐dominant locus for restless legs syndrome in French‐Canadians on chromosome 16p12.1 |
| 002457 |
Alex Rajput [Canada] ; Carles Vilari O-Güell [États-Unis] ; Michele L. Rajput [Canada] ; Owen A. Ross [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Sarah J. Lincoln [États-Unis] ; Stephanie A. Cobb [États-Unis] ; Michael G. Heckman [États-Unis] ; Matthew J. Farrer [États-Unis] ; Ali Rajput [Canada] | Alpha‐synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population |
| 002460 |
Teesta Soman [Canada] ; Thomas D. L. Steeves [Canada] ; Anthony E. Lang [Canada] | Alien hand syndrome and dystonia in a pediatric patient |
| 002468 |
Ana Djarmati [Allemagne] ; Johann Hagenah [Allemagne] ; Kathrin Reetz [Allemagne] ; Susen Winkler [Allemagne] ; Maria Isabel Behrens [Chili] ; Heike Pawlack [Allemagne] ; Katja Lohmann [Allemagne] ; Alfredo Ramirez [Allemagne] ; Vera Tadi [Allemagne] ; Norbert Brüggemann [Allemagne] ; Daniela Berg [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; Ferdinand Binkofski [Allemagne] ; Vladimir S. Kosti [Serbie] ; Jens Volkmann [Allemagne] ; Thomas Gasser [Allemagne] ; Christine Klein [Allemagne] | ATP13A2 variants in early‐onset Parkinson's disease patients and controls |
| 002477 |
Michelle K. Demos [Canada] ; Vincenzo Macri [Canada] ; Kevin Farrell [Canada] ; Tanya N. Nelson [Canada] ; Kristine Chapman [Canada] ; Eric Accili [Canada] ; Linlea Armstrong [Canada] | A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction |
| 002480 |
Bernard Ravina [États-Unis] ; Caroline Tanner [États-Unis] ; Diane Dieuliis [États-Unis] ; Shirley Eberly [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Stanley Fahn [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stephen Grate [États-Unis] ; Roger Kurlan [États-Unis] ; Anthony E. Lang [Canada] ; Kenneth Marek [États-Unis] ; Karl Kieburtz [États-Unis] ; David Oakes [États-Unis] ; Robin Elliott [États-Unis] ; Ira Shoulson [États-Unis] | A longitudinal program for biomarker development in Parkinson's disease: A feasibility study |
| 002483 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts |
| 002494 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Richard Camicioli [Canada] | Temporal Lobe Changes in Early, Untreated Parkinson's Disease |
| 002535 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] | rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: A PET study |
| 002571 |
Monty A. Silverdale [Canada, Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Anthony E. Lang [Canada] | The spectrum of orolingual tremor—A proposed classification system |
| 002603 |
Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins |
| 002646 |
Elena Moro [Canada] ; Panida Piboolnurak [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] | Reply: The variability of levodopa response in Parkinson's disease: Is sensitization reversible? |
| 002656 |
Alicia Semaka [Canada] ; Simon Warby [Canada] ; Blair R. Leavitt [Canada] ; Michael R. Hayden [Canada] | Re: Autopsy‐proven Huntington's disease with 29 trinucleotide repeats |
| 002679 |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Paula A. Rochon [Canada] ; Caroline M. Tanner [États-Unis] ; Gary Naglie [Canada] ; Anthony E. Lang [Canada] | Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial |
| 002695 |
Deborah Raymond [États-Unis] ; Rachel Saunders-Pullman [États-Unis] ; Patricia De Carvalho Aguiar [Brésil] ; Birgitt Schule [États-Unis] ; Norman Kock [Allemagne] ; Jennifer Friedman [États-Unis] ; Juliette Harris [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis] ; Gary A. Heiman [États-Unis] ; Danna Jennings [États-Unis] ; Dana Doheny [États-Unis] ; Mitchell F. Brin [États-Unis] ; Deborah De Leon Brin [États-Unis] ; Trisha Multhaupt-Buell [États-Unis] ; Anthony E. Lang [Canada] ; Roger Kurlan [États-Unis] ; Christine Klein [Allemagne] ; Laurie Ozelius [États-Unis] ; Susan Bressman [États-Unis] | Phenotypic spectrum and sex effects in eleven myoclonus‐dystonia families with ε‐sarcoglycan mutations |
| 002718 |
Pierre J. Blanchet [Canada] ; Romana Popovici [Canada] ; Francine Guitard [Canada] ; Pierre H. Rompré [Canada] ; Claude Lamarche [Canada] ; Gilles J. Lavigne [Canada] | Pain and denture condition in edentulous orodyskinesia: Comparisons with tardive dyskinesia and control subjects |
| 002735 |
Cory Toth [Canada] ; Martin Sutton Brown [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada] | Neuropathy as a potential complication of levodopa use in Parkinson's disease |
| 002756 |
Christopher G. Goetz [États-Unis] ; Barbara C. Tilley [États-Unis] ; Stephanie R. Shaftman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Matthew B. Stern [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results |
| 002774 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Katia Charland [Canada] ; Jacques Montplaisir [Canada] | Manifestations of Parkinson disease differ in association with REM sleep behavior disorder |
| 002793 |
Fabin Han [Canada] ; Lemuel Racacho [Canada] ; Howard Yang [Canada] ; Tara Read [Canada] ; Oksana Suchowersky [Canada] ; Anthony E. Lang [Canada] ; David A. Grimes [Canada] ; Dennis E. Bulman [Canada] | Large deletions account for an increasing number of mutations in SGCE |
| 002798 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Christopher C. Hanstock [Canada] ; Richard M. Camicioli [Canada] | Intact presupplementary motor area function in early, untreated Parkinson's disease |
| 002808 |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study |
| 002821 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial reactions in Parkinson's disease |
| 002840 |
Hu Liang Low [Canada, Royaume-Uni] ; Christopher R. Honey [Canada] | Focal childhood‐onset, action induced primary hip dystonia treated with pallidal deep brain stimulation |
| 002872 |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB |
| 002873 |
Jie-Yuan Li [Canada, Taïwan] ; Danny I. Cunic [Canada] ; Guillermo Paradiso [Canada] ; Carolyn Gunraj [Canada] ; Pramod K. Pal [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Electrophysiological features of myoclonus‐dystonia |
| 002900 |
Shen-Yang Lim [Australie] ; Michael J. Farrell [Australie] ; Stephen J. Gibson [Australie] ; Robert D. Helme [Australie] ; Anthony E. Lang [Canada] ; Andrew H. Evans [Australie] | Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? |
| 002904 |
Abdesslem Khiat [Canada] ; Yevgeniy Kuznetsov [Canada] ; Pierre J. Blanchet [Canada] ; Yvan Boulanger [Canada] | Diffusion‐weighted imaging and magnetization transfer imaging of tardive and edentulous orodyskinesia |
| 002908 |
Alberto J. Espay [États-Unis] ; Andrew P. Duker [États-Unis] ; Robert Chen [Canada] ; Michael S. Okun [États-Unis] ; Edwin T. Barrett [États-Unis] ; Johnna Devoto [États-Unis] ; Pamela Zeilman [États-Unis] ; Maureen Gartner [États-Unis] ; Noël Burton [États-Unis] ; Helard A. Miranda [États-Unis] ; George T. Mandybur [États-Unis] ; Theresa A. Zesiewicz [États-Unis] ; Kelly D. Foote [États-Unis] ; Fredy J. Revilla [États-Unis] | Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: Preliminary observations |
| 002924 |
Alison R. Oates [Canada] ; Jim S. Frank [Canada] ; Aftab E. Patla [Canada] ; Karen Vanooteghem [Canada] ; Fay B. Horak [États-Unis] | Control of dynamic stability during gait termination on a slippery surface in Parkinson's disease |
| 002929 |
Maria G. Motlagh [États-Unis, Iran] ; Arshia Seddigh [Iran, Royaume-Uni] ; Behnoosh Dashti [Iran] ; James F. Leckman [États-Unis] ; Javad Alaghband-Rad [Iran, Canada] | Consanguineous Iranian kindreds with severe Tourette syndrome |
| 002970 |
Eric J. Pappert [États-Unis] ; Terry Germanson [Canada] | Botulinum toxin type B vs. type A in toxin‐naïve patients with cervical dystonia: Randomized, double‐blind, noninferiority trial |
| 002977 |
Ali. H. Rajput [Canada] ; Christopher A. Robinson [Canada] ; Alexander H. Rajput [Canada] | Benign tremulous parkinsonism: A clinicopathological study |
| 002A28 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 002A72 |
FABIN HAN [Canada] ; Lemuel Racacho [Canada] ; Howard Yang [Canada] ; Tara Read [Canada] ; Oksana Suchowersky [Canada] ; Anthony E. Lang [Canada] ; David A. Grimes [Canada] ; Dennis E. Bulman [Canada] | Large Deletions Account for an Increasing Number of Mutations in SGCE |
| 002A75 |
HU LIANG LOW [Canada, Royaume-Uni] ; Christopher R. Honey [Canada] | Focal Childhood-Onset, Action Induced Primary Hip Dystonia Treated with Pallidal Deep Brain Stimulation |
| 002B11 |
Asha Kishore [Canada] ; Alberto J. Espay [Canada] ; Connie Marras [Canada] ; Thamer Al-Khairalla [Canada] ; Tamara Arenovich [Canada] ; Abena Asante [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] | Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: Differential effects on bradykinesia |
| 002B15 |
Calvin Melmed [Canada] ; Daniel Moros [États-Unis] ; Howard Rutman [États-Unis] | Treatment of essential tremor with the barbiturate t2000 (1,3‐dimethoxymethyl‐5,5‐diphenyl‐barbituric acid) |
| 002B44 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 002B48 |
Matthew O. Hebb [Canada] ; Paula Chiasson [Canada] ; Anthony E. Lang [Canada] ; Robert M. Brownstone [Canada] ; Ivar Mendez [Canada] | Sustained relief of dystonia following cessation of deep brain stimulation |
| 002B55 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Ji Hyun Ko [Canada] ; Yu-Yan Poon [Canada] ; Elena Moro [Canada] | Subdural motor cortex stimulation in Parkinson's disease does not modify movement‐related rCBF pattern |
| 002B58 |
Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada] | Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia |
| 002C22 |
Fabin Han [Canada] ; Lemuel Racacho [Canada] ; Anthony E. Lang [Canada] ; Dennis E. Bulman [Canada] ; David A. Grimes [Canada] | Refinement of the DYT15 locus in myoclonus dystonia |
| 002C27 |
Ana Djarmati [Allemagne] ; Miodrag Gužvi [Allemagne, Serbie] ; Anne Grünewald [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; David K. Simon [États-Unis] ; Angela M. Kaindl [Allemagne] ; Peter Vieregge [Allemagne] ; Anders O. H. Nygren [Pays-Bas] ; Christian Beetz [Allemagne] ; Katja Hedrich [Allemagne] ; Christine Klein [Allemagne] | Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation‐dependent probe amplification |
| 002C39 |
Janis M. Miyasaki [Canada] ; Khalid Al Hassan [Canada] ; Anthony E. Lang [Canada] ; Valerie Voon [Canada] | Punding prevalence in Parkinson's disease |
| 002C42 |
Yevgeniy Kuznetsov [Canada] ; Abdesslem Khiat [Canada] ; Pierre J. Blanchet [Canada] ; Yvan Boulanger [Canada] | Proton magnetic resonance spectroscopy study of dyskinesia patients |
| 002C43 |
Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada] | Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle |
| 002C62 |
Normand Teasdale [Canada] ; Olivier Hue [Canada] ; Martin Simoneau [Canada] ; Angelo Tremblay [Canada] ; Picard Marceau [Canada] ; Simon Marceau [Canada] | Predictors of weight loss in Parkinson's disease: Is weight loss the chicken or the egg? |
| 002D00 |
Rob M. A. De Bie [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] | Orthostatic tremor in progressive supranuclear palsy |
| 002D34 |
Christopher G. Goetz [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Matthew B. Stern [États-Unis] ; Barbara C. Tilley [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan |
| 002D38 |
Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada] | Mood stability during acute stimulator challenge in Parkinson's disease patients under long‐term treatment with subthalamic deep brain stimulation |
| 002D46 |
Dan A. Mendonça [Canada] ; Krishe Menezes [Canada] ; Mandar S. Jog [Canada] | Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial |
| 002D57 |
Richard M. Camicioli [Canada] ; Christopher C. Hanstock [Canada] ; Thomas P. Bouchard [Canada] ; Myrlene Gee [Canada] ; Nancy J. Fisher [Canada] ; W. R. Wayne Martin [Canada] | Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease |
| 002D72 |
Giovanni Fabbrini [Italie] ; Jonathan M. Brotchie [Canada] ; Francisco Grandas [Espagne] ; Masahiro Nomoto [Japon] ; Christopher G. Goetz [États-Unis] | Levodopa‐induced dyskinesias |
| 002D75 |
Panida Piboolnurak [Canada, Thaïlande] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elena Moro [Canada] | Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease |
| 002D83 |
Steven A. Gunzler [États-Unis] ; A. Jon Stoessl [Canada] ; Robert A. Egan [États-Unis] ; Richard G. Weleber [États-Unis] ; Paul Wang [États-Unis] ; John G. Nutt [États-Unis] | Joubert syndrome surviving to adulthood associated with a progressive movement disorder |
| 002D88 |
Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | Is there seasonal variation in risk of Parkinson's disease? |
| 002D95 |
Jie-Yuan Li [Canada, Taïwan] ; Alberto J. Espay [Canada] ; Carolyn A. Gunraj [Canada] ; Pramod K. Pal [Canada] ; Danny I. Cunic [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Interhemispheric and ipsilateral connections in Parkinson's disease: Relation to mirror movements |
| 002E33 |
Jong Sam Baik [Canada, Corée du Sud] ; Anthony E. Lang [Canada] | Gait abnormalities in psychogenic movement disorders |
| 002E37 |
Irena Rektorova [République tchèque] ; Jennifer Barrett [Canada] ; Michal Mikl [République tchèque] ; Ivan Rektor [République tchèque] ; Tomas Paus [Canada, Royaume-Uni] | Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson's disease |
| 002E84 |
Quincy J. Almeida [Canada] ; James S. Frank [Canada] ; Eric A. Roy [Canada] ; Aftab E. Patla [Canada] ; Mandar S. Jog [Canada] | Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease |
| 002E97 |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
| 002E98 |
Anne Crochard [France] ; Abdelkader El Hasnaoui [France] ; Denis Pouchain [France] ; Dominique Huas [France] ; Isabelle Arnulf [France] ; Jean Krieger [France] ; Eric Lainey [France] ; Philippe Le Jeunne [France] ; Damien Leger [France] ; Stéphane Schuck [France] ; Nathalie Texier [France] ; François Tison [France] ; Jacques Montplaisir [Canada] | Diagnostic indicators of restless legs syndrome in primary care consultations: The DESYR study |
| 002F52 |
Maria Björkqvist [Suède] ; Blair R. Leavitt [Canada] ; Jörgen E. Nielsen [Danemark] ; Bernhard Landwehrmeyer [Allemagne] ; Daniel Ecker [Allemagne] ; Hindrik Mulder [Suède] ; Patrik Brundin [Suède] ; Sa Petersén [Suède] | Cocaine‐ and amphetamine‐regulated transcript is increased in Huntington disease |
| 002F56 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
| 002F91 |
Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] | Benign hereditary chorea revisited: A journey to understanding |
| 003000 |
Bryan Young [Canada] ; Albert Driedger [Canada] ; John Wojcik [Canada] | Autoimmune thyroid disease and segmental myoclonus |
| 003006 |
Xuemei Huang [États-Unis] ; Yueh Z. Lee [États-Unis] ; Martin Mckeown [Canada] ; Guido Gerig [États-Unis] ; Hongbin Gu [États-Unis] ; Weili Lin [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Sutapa Ford [États-Unis] ; Alexander I. Tröster [États-Unis] ; Daniel R. Weinberger [États-Unis] ; Martin Styner [États-Unis] | Asymmetrical ventricular enlargement in Parkinson's disease |
| 003017 |
Connie Marras [Canada] ; Alexander Kopp [Canada] ; Feng Qiu [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada] | Antipsychotic use in older adults with Parkinson's disease |
| 003058 |
Ruth M. Pickering [Royaume-Uni] ; Yvette A. M. Grimbergen [Pays-Bas] ; Una Rigney [Royaume-Uni] ; Ann Ashburn [Royaume-Uni] ; Gordon Mazibrada [Royaume-Uni] ; Brian Wood [Royaume-Uni] ; Peggy Gray [Canada] ; Graham Kerr [Australie] ; Bastiaan R. Bloem [Pays-Bas] | A meta‐analysis of six prospective studies of falling in Parkinson's disease |
| 003077 |
FABIN HAN [Canada] ; Lemuel Racacho [Canada] ; Anthony E. Lang [Canada] ; Dennis E. Bulman [Canada] ; David A. Grimes [Canada] | Refinement of the DYT15 locus in myoclonus dystonia |
| 003091 |
JONG SAM BAIK [Canada, Corée du Sud] ; Anthony E. Lang [Canada] | Gait abnormalities in psychogenic movement disorders |
| 003105 |
Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] | Benign Hereditary Chorea Revisited : A Journey to Understanding |
| 003107 |
XUEMEI HUANG [États-Unis] ; Yueh Z. Lee [États-Unis] ; Martin Mckeown [Canada] ; Guido Gerig [États-Unis] ; HONGBIN GU [États-Unis] ; WEILI LIN [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Sutapa Ford [États-Unis] ; Alexander I. Troster [États-Unis] ; Daniel R. Weinberger [États-Unis] ; Martin Styner [États-Unis] | Asymmetrical ventricular enlargement in Parkinson's disease |
| 003144 |
David A. Grimes [Canada] ; Fabin Han [Canada] ; Michel Panisset [Canada] ; Lemuel Racacho [Canada] ; Fengxia Xiao [Canada] ; Ruobing Zou [Canada] ; Kelly Westaff [Canada] ; Dennis E. Bulman [Canada] | Translated mutation in the Nurr1 gene as a cause for Parkinson's disease |
| 003169 |
Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] | Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes |
| 003197 |
Jacques Montplaisir [Canada] ; Jeff Karrasch [Australie] ; Jean Haan [Allemagne] ; Dieter Volc [Autriche] | Ropinirole is effective in the long‐term management of restless legs syndrome: A randomized controlled trial |
| 003224 |
Alberto J. Espay [Canada, États-Unis] ; Catherine Bergeron [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] | Rapidly progressive sporadic dentatorubral pallidoluysian atrophy with intracytoplasmic inclusions and no CAG repeat expansion |
| 003245 |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin |
| 003283 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
| 003300 |
Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies |
| 003308 |
Satoshi Kaneko [Japon] ; Toshitaka Kawarai [Canada] ; Edwin Yip [Canada] ; Shabnam Salehi-Rad [Canada] ; Christine Sato [Canada] ; Antonio Orlacchio [Italie] ; Giorgio Bernardi [Italie] ; Yan Liang [Canada] ; Hiroshi Hasegawa [Canada] ; Ekaterina Rogaeva [Canada] ; Peter St George-Hyslop [Canada] | Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia |
| 003399 |
Cindy Zadikoff [Canada] ; Ekaterina Rogaeva [Canada] ; Ana Djarmati [Allemagne] ; Christine Sato [Canada] ; Shabnam Salehi-Rad [Canada] ; Peter St. George-Hyslop [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] | Homozygous and heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients |
| 003415 |
Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] ; Ali R. Rezai [États-Unis] | Guest editors' introduction |
| 003422 |
Judith A. Strong [États-Unis] ; Arif Dalvi [États-Unis] ; Fredy J. Revilla [États-Unis] ; Alok Sahay [États-Unis] ; Frederick J. Samaha [États-Unis] ; Jeffrey A. Welge [États-Unis] ; Jianhua Gong [États-Unis, Canada] ; Maureen Gartner [États-Unis] ; Xia Yue [États-Unis] ; Lei Yu [États-Unis, Canada] | Genotype and smoking history affect risk of levodopa‐induced dyskinesias in Parkinson's disease |
| 003438 |
Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation |
| 003491 |
Ruth H. Walker [États-Unis] ; Adrian Danek [Allemagne] ; Carol Dobson-Stone [Australie] ; Renzo Guerrini [Italie] ; Hans H. Jung [Suisse] ; Anne-Louise Lafontaine [Canada] ; Luca Rampoldi [Italie] ; François Tison [France] ; Eva Andermann [Canada] | Developments in neuroacanthocytosis: Expanding the spectrum of choreatic syndromes |
| 003492 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 003495 |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation: Preoperative issues |
| 003496 |
Günther Deuschl [Allemagne] ; Jan Herzog [Allemagne] ; Galit Kleiner-Fisman [États-Unis] ; Cynthia Kubu [États-Unis] ; Andres M. Lozano [Canada] ; Kelly E. Lyons [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Filippo Tamma [Italie] ; Alexander I. Tröster [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Jens Volkmann [Allemagne] ; Valerie Voon [États-Unis] | Deep brain stimulation: Postoperative issues |
| 003497 |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation: Neuropsychological and neuropsychiatric issues |
| 003498 |
Matthew O. Hebb [Canada] ; Paula Gaudet [Canada] ; Ivar Mendez [Canada] | Deep brain stimulation to treat hyperkinetic symptoms of cockayne syndrome |
| 003500 |
Alim-Louis Benabid [France] ; Günther Deuschl [Allemagne] ; Anthony E. Lang [Canada] ; Kelly E. Lyons [États-Unis] ; Ali R. Rezai [États-Unis] | Deep brain stimulation for Parkinson's disease |
| 003504 |
Todd B. Sherer [États-Unis] ; Brian K. Fiske [États-Unis] ; Clive N. Svendsen [États-Unis] ; Anthony E. Lang [Canada] ; J. William Langston [États-Unis] | Crossroads in GDNF therapy for Parkinson's disease |
| 003531 |
Renato P. Munhoz [Brésil] ; Toshitaka Kawarai [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Christine Sato [Canada] ; Yan Liang [Canada] ; Peter H. St. George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada] | Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus) |
| 003542 |
Anne Pavy-Le Traon [France] ; Richard L. Hughson [Canada] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Nelly Fabre [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Cerebral autoregulation is preserved in multiple system atrophy: A transcranial Doppler study |
| 003571 |
Jens Volkmann [Allemagne] ; Elena Moro [Canada] ; Rajesh Pahwa [États-Unis] | Basic algorithms for the programming of deep brain stimulation in Parkinson's disease |
| 003589 |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 003625 |
Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] | Subthalamic nucleus deep brain stimulation : Summary and meta-analysis of outcomes |
| 003663 |
Anne Pavy-Le Traon [France] ; Richard L. Hughson [Canada] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Nelly Fabre [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Cerebral autoregulation is preserved in multiple system atrophy : A transcranial doppler study |
| 003673 |
Victor Lun [Canada] ; Nancy Pullan [Canada] ; Nancy Labelle [Canada] ; Corey Adams [Canada] ; Oksana Suchowersky [Canada] | Comparison of the effects of a self‐supervised home exercise program with a physiotherapist‐supervised exercise program on the motor symptoms of Parkinson's disease |
| 003694 |
Anthony E. Lang [Canada] | Treatment of progressive supranuclear palsy and corticobasal degeneration |
| 003700 |
Monty A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Canada] | Topiramate reduces levodopa‐induced dyskinesia in the MPTP‐lesioned marmoset model of Parkinson's disease |
| 003712 |
Cathrin M. Bütefisch [États-Unis, Allemagne] ; Babak Boroojerdi [États-Unis] ; Robert Chen [États-Unis, Canada] ; Fortunato Battaglia [États-Unis] ; Mark Hallett [États-Unis] | Task‐dependent intracortical inhibition is impaired in focal hand dystonia |
| 003738 |
Eva Andermann [Canada] ; Adrian Danek [Allemagne] ; Glenn Irvine [Royaume-Uni] ; Hans H. Jung [Suisse] ; Luca Rampoldi [Italie] ; François Tison [France] ; Ruth H. Walker [États-Unis] | Second International Neuroacanthocytosis Symposium: Expanding the spectrum of choreatic syndromes: Montreal Neurological Hospital and Institute, April 17–19 |
| 003739 |
Melisa Proulx [Canada] ; François P. De Courval [Canada] ; Michael A. Wiseman [Canada] ; Michel Panisset [Canada] | Salivary production in Parkinson's disease |
| 003751 |
Valerie Voon [Canada, États-Unis] | Reply: Repetitive behaviors in Parkinson's disease |
| 003803 |
Andrew Nataraj [Canada] ; Ali H. Rajput [Canada] | Parkinson's disease, stroke, and related epidemiology |
| 003809 |
Adrian P. Fawcett [Canada] ; Elena Moro [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease |
| 003820 |
Asha Kishore [Canada] ; Anthony E. Lang [Canada] | Normalization of voice in spasmodic dysphonia during transient global amnesia |
| 003823 |
Jonathan M. Brotchie [Canada] | Nondopaminergic mechanisms in levodopa‐induced dyskinesia |
| 003892 |
Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] | Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment |
| 003910 |
Julie-Christine Lévesque [Canada] ; André Parent [Canada] | GABAergic interneurons in human subthalamic nucleus |
| 003938 |
Julie Carrier [Canada] ; Sonia Frenette [Canada] ; Jacques Montplaisir [Canada] ; Jean Paquet [Canada] ; Caroline Drapeau [Canada] ; Jocelyn Morettini [Canada] | Effects of periodic leg movements during sleep in middle‐aged subjects without sleep complaints |
| 003943 |
Pershia Samadi [Canada] ; Laurent Grégoire [Canada] ; Arash Rassoulpour [États-Unis] ; Paolo Guidetti [États-Unis] ; Emanuela Izzo [Italie] ; Robert Schwarcz [États-Unis] ; Paul J. Bédard [Canada] | Effect of kynurenine 3‐hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in parkinsonian monkeys |
| 003950 |
Ronald B. Postuma [Canada] ; Tamara Arenovich [Canada] ; Anthony E. Lang [Canada] | Does severity of Parkinson's disease vary according to season? |
| 003958 |
Naushad Hirani [Canada] ; Charles C. Bayliff [Canada] ; David G. Mccormack [Canada] | Diagnosis and management of pergolide‐induced fibrosis |
| 003978 |
Antonio Orlacchio [Italie] ; Toshitaka Kawarai [Canada] ; Fabrizio Gaudiello [Italie] ; Antonio Totaro [Italie] ; Orazio Schillaci [Italie] ; Alessandro Stefani [Italie] ; Roberto Floris [Italie] ; Peter H. St. George-Hyslop [Canada] ; Sandro Sorbi [Italie] ; Giorgio Bernardi [Italie] | Clinical and genetic study of a large SPG4 Italian family |
| 003986 |
Anne Beuter [France] ; Emilie Barbo [Canada] ; Robert Rigal [Canada] ; Pierre J. Blanchet [Canada] | Characterization of subclinical tremor in Parkinson's disease |
| 003A07 |
Joy M. A. Muthipeedika [Inde] ; Ahsan Moosa [Inde] ; Anand Kumar [Inde] ; Oksana Suchowersky [Canada] | Bilateral chorea–ballism associated with hyperthyroidism |
| 003A17 |
Richard Camicioli [Canada] ; Ali Rajput [Canada] ; Michelle Rajput [Canada] ; Christian Reece [Canada] ; Haydeh Payami [États-Unis] ; Chunhai Hao [Canada] ; Alex Rajput [Canada] | Apolipoprotein E ϵ4 and catechol‐O‐methyltransferase alleles in autopsy‐proven Parkinson's disease: Relationship to dementia and hallucinations |
| 003A24 |
Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; Yan Meng [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada] | Analysis of the glucocerebrosidase gene in Parkinson's disease |
| 003A27 |
Galit Kleiner-Fisman [États-Unis] ; Noel Y. Calingasan [États-Unis] ; Mary Putt [États-Unis] ; June Chen [États-Unis] ; M. Flint Beal [États-Unis] ; Anthony E. Lang [Canada] | Alterations of striatal neurons in benign hereditary chorea |
| 003A40 |
Samer Karamohamed [États-Unis] ; L. I. Golbe [États-Unis] ; M. H. Mark [États-Unis] ; A. M. Lazzarini [États-Unis] ; O. Suchowersky [Canada] ; N. Labelle [Canada] ; Mark Guttman [Canada] ; L. J. Currie [États-Unis] ; G. F. Wooten [États-Unis] ; M. Stacy [États-Unis] ; M. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; J. Liu [États-Unis] ; C. M. Shoemaker [États-Unis] ; J. B. Wilk [États-Unis] ; A. L. Destefano [États-Unis] ; J. C. Latourelle [États-Unis] ; G. Xu [États-Unis] ; R. Watts [États-Unis] ; J. Growdon [États-Unis] ; M. Lew [États-Unis] ; C. Waters [États-Unis] ; P. Vieregge [Allemagne] ; P. P. Pramstaller [Italie] ; C. Klein [Allemagne] ; B. A. Racette [États-Unis] ; J. S. Perlmutter [États-Unis] ; A. Parsian [États-Unis] ; Carlos Singer [États-Unis] ; E. Montgomery [États-Unis] ; K. Baker [États-Unis] ; J. F. Gusella [États-Unis] ; A. Herbert [États-Unis] ; R. H. Myers [États-Unis] | Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ‐1 (T497C) genes in familial Parkinson's disease from the GenePD study |
| 003A76 |
Galit Kleiner-Fisman [États-Unis] ; Noel Y. Calingasan [États-Unis] ; Mary Putt [États-Unis] ; June Chen [États-Unis] ; M. Flint Beal [États-Unis] ; Anthony E. Lang [Canada] | Alterations of striatal neurons in benign hereditary chorea |
| 003A88 |
Michael Samuel [Canada] ; Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] | Voluntary control and a wider clinical spectrum of essential palatal tremor |
| 003A99 |
Constantine Constantoyannis [Canada] ; Ajit Kumar [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Tremor induced by thalamic deep brain stimulation in patients with complex regional facial pain |
| 003B17 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Orit Zamir [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elspeth Sime [Canada] ; Jean A. Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations |
| 003B21 |
Amanpreet Badhwar [Canada] ; An Jansen [Canada] ; Frederick Andermann [Canada] ; Massimo Pandolfo [Canada] ; Eva Andermann [Canada] | Striking intrafamilial phenotypic variability and spastic paraplegia in the presence of similar homozygous expansions of the FRDA1 gene |
| 003B25 |
Renato P. Munhoz [Canada] ; Catherine Bergeron [Canada] ; Anthony E. Lang [Canada] | Sporadic case of dentatorubral pallidoluysian atrophy with no CAG repeat expansion and no intranuclear inclusions |
| 003B32 |
Judit Horvath [Suisse] ; Robin D. Fross [États-Unis] ; Galit Kleiner-Fisman [Canada] ; René Lerch [Suisse] ; Hans Stalder [Suisse] ; Suzanne Liaudat [Suisse] ; William J. Raskoff [États-Unis] ; Keith D. Flachsbart [États-Unis] ; Harry Rakowski [Canada] ; Jean-Claude Pache [Suisse] ; Pierre R. Burkhard [Suisse] ; Anthony E. Lang [Canada] | Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists |
| 003B51 |
P. Lespérance [Canada] ; N. Djerroud [Canada] ; A. Diaz Anzaldua [Canada] ; G. A. Rouleau [Canada] ; S. Chouinard [Canada] ; F. Richer [Canada] | Restless legs in Tourette syndrome |
| 003B59 |
Valerie Voon [Canada] | Repetition, repetition, and repetition: Compulsive and punding behaviors in parkinson's disease |
| 003B68 |
Connie Marras [Canada] | Re: Cabergoline versus levodopa monotherapy: A decision analysis |
| 003B70 |
Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] ; Catherine Bergeron [Canada] ; David J. Burn [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] | Rapidly progressive behavioral changes and parkinsonism in a 68‐year‐old man |
| 003B73 |
Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada] | Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations |
| 003B82 |
Sarah Furtado [Canada] ; Haydeh Payami [États-Unis] ; Paul J. Lockhart [États-Unis] ; Melissa Hanson [États-Unis] ; John G. Nutt [États-Unis] ; Andrew A. Singleton [États-Unis] ; Amanda Singleton [États-Unis] ; Jamel Bower [États-Unis] ; Ryan J. Utti [États-Unis] ; Thomas D. Bird [États-Unis] ; Raul De La Fuente-Fernandez [Canada] ; Yoshio Tsuboi [États-Unis] ; Mary L. Klimek [Canada] ; Oksana Suchowersky [Canada] ; John Hardy [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; A. Jon Stoessl [Canada] | Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2) |
| 003B85 |
Pierre J. Blanchet [Canada] ; Ossob Abdillahi [Canada] ; Chantale Beauvais [Canada] ; Pierre H. Rompré [Canada] ; Gilles J. Lavigne [Canada] | Prevalence of spontaneous oral dyskinesia in the elderly: A reappraisal |
| 003B88 |
Galit Kleiner-Fisman [Canada] ; Catherine Bergeron [Canada] ; Anthony E. Lang [Canada] | Presentation of Creutzfeldt–Jakob disease as acute corticobasal degeneration syndrome |
| 003C23 |
Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada] | Parkinsonism in Ontario: Comorbidity associated with hospitalization in a large cohort |
| 003C37 |
Susan Fox [Royaume-Uni] ; Montague Silverdale [Royaume-Uni] ; Mark Kellett [Royaume-Uni] ; Rhys Davies [Royaume-Uni] ; Malcolm Steiger [Royaume-Uni] ; Nicholas Fletcher [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie [Royaume-Uni, Canada] | Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease |
| 003C44 |
Luiz C. M. Pereira [Canada] ; Vanessa N. Palter [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Neuronal activity in the globus pallidus of multiple system atrophy patients |
| 003C48 |
Alex Desautels [Canada] ; Gustavo Turecki [Canada] ; Lan Xiong [Canada] ; Daniel Rochefort [Canada] ; Jacques Montplaisir [Canada] ; Guy A. Rouleau [Canada] | Mutational analysis of neurotensin in familial restless legs syndrome |
| 003C69 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 003D03 |
Renato P. Munhoz [Canada] ; Anthony E. Lang [Canada] | Gestes antagonistes in psychogenic dystonia |
| 003D11 |
Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] | Farewell from the outgoing editors |
| 003D34 |
Yih-Ru Wu [Taïwan] ; Guey-Jen Lee-Chen [Taïwan] ; Anthony E. Lang [Canada] ; Chiung-Mei Chen [Taïwan] ; Hsuan-Yuan Lin [Taïwan] ; Sien-Tsong Chen [Taïwan] | Dystonia as a presenting sign of spinocerebellar ataxia type 1 |
| 003D42 |
Katja Hedrich [Allemagne] ; Cordula Eskelson [Allemagne] ; Beth Wilmot [États-Unis] ; Karen Marder [États-Unis] ; Juliette Harris [États-Unis] ; Jennifer Garrels [Allemagne] ; Helen Meija-Santana [États-Unis] ; Peter Vieregge [Allemagne] ; Helfried Jacobs [Allemagne] ; Susan B. Bressman [États-Unis] ; Anthony E. Lang [Canada] ; Martin Kann [Allemagne] ; Giovanni Abbruzzese [Italie] ; Paolo Martinelli [Italie] ; Eberhard Schwinger [Allemagne] ; Laurie J. Ozelius [États-Unis] ; Peter P. Pramstaller [Italie, États-Unis] ; Christine Klein [Allemagne] ; Patricia Kramer [États-Unis] | Distribution, type, and origin of Parkin mutations: Review and case studies |
| 003D53 |
Eugene Tunik [États-Unis] ; Sergei V. Adamovich [États-Unis] ; Howard Poizner [États-Unis] ; Anatol G. Feldman [Canada] | Deficits in rapid adjustments of movements according to task constraints in Parkinson's disease |
| 003D97 |
Hazem A. Eltahawy [Canada] ; Anthony Feinstein [Canada] ; Farouk Khan [Canada] ; Jean Saint-Cyr [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] | Bilateral globus pallidus internus deep brain stimulation in tardive dyskinesia: A case report |
| 003E17 |
Cory Toth [Canada] ; Michelle Rajput [Canada] ; Ali H. Rajput [Canada] | Anomalies of asymmetry of clinical signs in parkinsonism |
| 003E21 |
Yoshiaki Furukawa [Canada] ; James J. Filiano [États-Unis] ; Stephen J. Kish [Canada] | Amantadine for levodopa‐induced choreic dyskinesia in compound heterozygotes for GCH1 mutations |
| 003E40 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Orit Zamir [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elspeth Sime [Canada] ; Jean A. Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations |
| 003E46 |
Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] ; Catherine Bergeron [Canada] ; David J. Burn [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] | Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man |
| 003E49 |
Galit Kleiner-Fisman [Canada] ; Catherine Bergeron [Canada] ; Anthony E. Lang [Canada] | Presentation of Creutzfeldt-Jakob disease as acute corticobasal degeneration syndrome |
| 003E53 |
Adrian P. Fawcett [Canada] ; Ilena Moro [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease |
| 003E82 |
Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; YAN MENG [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada] | Analysis of the glucocerebrosidase gene in Parkinson's disease |
| 003E89 |
Stephen J. Kish [Canada] | What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease? |
| 003F00 |
Alberto J. Espay [Canada] ; Peter Ashby [Canada] ; Ritsuko Hanajima [Canada] ; Mandar S. Jog [Canada] ; Anthony E. Lang [Canada] | Unique form of propriospinal myoclonus as a possible complication of an enteropathogenic toxin |
| 003F96 |
Daniel S. Sa [Canada] ; Angela Mailis-Gagnon [Canada] ; Keith Nicholson [Canada] ; Anthony E. Lang [Canada] | Posttraumatic painful torticollis |
| 003F98 |
Andrew Kertesz [Canada] | Pick's complex and FTDP‐17 |
| 004014 |
Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis] | Parkinson's disease is associated with hippocampal atrophy |
| 004024 |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset |
| 004026 |
Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
| 004029 |
Galit Kleiner-Fisman [Canada] ; Sandra E. Black [Canada] ; Anthony E. Lang [Canada] | Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist |
| 004036 |
Anthoy E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Günther Deuschl [Allemagne] ; Christopher Goetz [États-Unis] | Movement disorders offers electronic manuscript submission |
| 004054 |
Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada] | Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair |
| 004058 |
Zelma H. T. Kiss [Canada] ; Marshall Wilkinson [Canada] ; Jerry Krcek [Canada] ; Oksana Suchowersky [Canada] ; Bin. Hu [Canada] ; William F. Murphy [Canada] ; Doug Hobson [Canada] ; Ron R. Tasker [Canada] | Is the target for thalamic deep brain stimulation the same as for thalamotomy? |
| 004086 |
Allan L. Adkin [Canada] ; James S. Frank [Canada] ; Mandar S. Jog [Canada] | Fear of falling and postural control in Parkinson's disease |
| 004116 |
Ronald B. Postuma [États-Unis] ; Yoshiaki Furukawa [Canada, États-Unis] ; Ekaterina Rogaeva [Canada, États-Unis] ; Peter H. St. George-Hyslop [Canada, États-Unis] ; Matt J. Farrer [Canada, États-Unis] ; Anthony E. Lang [États-Unis] | Dopa‐responsive dystonia presenting with prominent isolated bilateral resting leg tremor: Evidence for a role of parkin? |
| 004137 |
Taresa Stefurak [Canada] ; David Mikulis [Canada] ; Helen Mayberg [Canada] ; Anthony E. Lang [Canada] ; Stephanie Hevenor [Canada] ; Peter Pahapill [États-Unis] ; Jean Saint-Cyr [Canada] ; Andres Lozano [Canada] | Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study |
| 004141 |
Anthony E. Lang [Canada] | Corticobasal degeneration: Selected developments |
| 004142 |
Anthony E. Lang [Canada] | Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look‐alike? |
| 004155 |
Nancy Bélanger [Canada] ; Laurent Grégoire [Canada] ; Abdallah Hadj Tahar [Canada] ; Paul J. Bédard [Canada] | Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeys |
| 004160 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa‐induced motor complications |
| 004166 |
Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada] | Burden of parkinsonism: A population‐based study |
| 004187 |
Renato P. Munhoz [Canada] ; Ritsuko Hanajima [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada] | Acute effect of transcutaneous electrical nerve stimulation on tremor |
| 004210 |
Galit Kleiner-Fisman [Canada] ; Sandra E. Black [Canada] ; Anthony E. Lang [Canada] | Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist |
| 004234 |
Pramod K. Pal [Canada] ; Joanne Leung [États-Unis] ; Katya Hedrich [Allemagne] ; Ali Samii [Canada] ; Abraham Lieberman [États-Unis] ; Paul A. Nausieda [États-Unis] ; Donald B. Calne [Canada] ; Xandra O. Breakefield [États-Unis] ; Christine Klein [Allemagne] ; A. Jon Stoessl [Canada] | [18F]‐Dopa positron emission tomography imaging in early‐stage, non‐parkin juvenile parkinsonism |
| 004250 |
Manavdeep Grewal [Canada] ; Raed Hawa [Canada] ; Colin Shapiro [Canada] | Treatment of periodic limb movements in sleep with selegiline HCl |
| 004276 |
Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis] | Surgery of the motor thalamus: Problems with the present nomenclatures |
| 004279 |
H. Christopher Hyson [Canada] ; Andrew M. Johnson [Canada] ; Mandar S. Jog [Canada] | Sublingual Atropine for sialorrhea secondary to parkinsonism: A pilot study |
| 004313 |
Frederick Andermann [Canada] | Rasmussen Syndrome and movement disorder |
| 004321 |
Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery R. Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada] | Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases |
| 004377 |
Aman Badhwar [Canada] ; Auli Siren [Canada] ; Eva Andermann [Canada] ; Frederick Andermann [Canada] | Myoclonic status epilepticus: Video presentation |
| 004384 |
Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Microelectrode recordings in the pallidum |
| 004389 |
Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] | Mechanisms of deep brain stimulation |
| 004397 |
G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A. Lafontaine [Canada] ; O. Suchowersky [Canada] | Long‐term efficacy of botulinum toxin A in treatment of various movement disorders over a 10‐year period |
| 004411 |
David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada] | Large French‐Canadian family with Lewy body parkinsonism: Exclusion of known loci |
| 004413 |
André Parent [Canada] | Jules Bernard Luys and the subthalamic nucleus |
| 004436 |
David A. Grimes [Canada] ; Fabin Han [Canada] ; Dennise Bulman [Canada] ; Mary Lou Nicolson [Canada] ; Oksana Suchowersky [Canada] | Hereditary chin trembling: A new family with exclusion of the chromosome 9q13‐q21 Locus |
| 004445 |
Sian D. Spacey [Royaume-Uni, Canada] ; Enza-Maria Valente [Royaume-Uni, Italie] ; Gurusidheshwar M. Wali [Inde] ; Thomas T. Warner [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Peter H. Dixon [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: Evidence for a third EKD gene |
| 004479 |
Martin Michaud [Canada] ; Gilles Lavigne [Canada] ; Alex Desautels [Canada] ; Gaétan Poirier [Canada] ; Jacques Montplaisir [Canada] | Effects of immobility on sensory and motor symptoms of restless legs syndrome |
| 004481 |
Guillermo Paradiso [Canada] ; Farooq Khan [Canada] ; Robert Chen [Canada] | Effects of apomorphine on flexor reflex and periodic limb movement |
| 004514 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
| 004532 |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
| 004535 |
Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche] | Clinical–Pathological study of levodopa complications |
| 004557 |
Quincy J. Almeida [Canada] ; Laurie R. Wishart [Canada] ; Timothy D. Lee [Canada] | Bimanual coordination deficits with Parkinson's disease: The influence of movement speed and external cueing |
| 004589 |
Pramod K. Pal [Canada] ; Joanne Leung [États-Unis] ; Katya Hedrich [Allemagne] ; Ali Samii [Canada] ; Abraham Lieberman [États-Unis] ; Paul A. Nausieda [États-Unis] ; Donald B. Calne [Canada] ; Xandra O. Breakefield [États-Unis] ; Christine Klein [Allemagne] ; A. Jon Stoessl [Canada] | [18F]-dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism |
| 004664 |
J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis] | Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled study |
| 004668 |
Andres M. Lozano [Canada] | The subthalamic nucleus: Myth and opportunities |
| 004704 |
Richard Camicioli [Canada] | Reply |
| 004732 |
Alex Birnbaum [Canada] | Parkinson's disease and movement disorders: Diagnosis and treatment guidelines for the practicing physician, Charles Adler and Eric Ahlskog, eds. |
| 004733 |
Y. R. Wu [Taïwan] ; P. Ashby [Canada] ; A. E. Lang [Canada] | Orthostatic tremor arises from an oscillator in the posterior fossa |
| 004751 |
Massimo Pandolfo [Canada] | Molecular basis of Friedreich ataxia |
| 004754 |
Mandar S. Jog [Canada] ; Linda Grantier [Canada] | Methods for digital video recording, storage, and communication of movement disorders |
| 004765 |
Marie-Hélène Saint-Hilaire [États-Unis] ; Jean-Marc Saint-Hilaire [Canada] | Jumping Frenchmen of Maine |
| 004775 |
Dennis W. Dickson [États-Unis] ; Brian Anderton [Royaume-Uni] ; Huw Morris [Royaume-Uni] ; John Hodges [Royaume-Uni] ; Thomas H. Bak [Royaume-Uni] ; B. Dubois [France] ; B. Pillon [France] ; T. Bak [France] ; R. Rafal [France] ; J. Grafman [France] ; Lawrence I. Golbe [États-Unis] ; John Steele [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Marie Vidailhet [France] ; S. Rivaud-Pechoux [France] ; Irene Livan [États-Unis] ; Charles Pierrot-Deseilligny [France] ; Clare J. Fowler [Royaume-Uni] ; Timothy Lynch [Irlande (pays)] ; Catherine Bergeron [Canada] ; Kailash Bhatia [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] ; Gregor K. Wenning [États-Unis, Royaume-Uni, France, Irlande (pays), Canada, Allemagne] ; Christopher J. Mathias [Royaume-Uni] ; Thomas Klockgether [Allemagne] ; M. Abele [Allemagne] ; U. Wullner [Allemagne] ; Peter Lantos [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Dominique Caparros-Lefebvre [France] | International Medical Workshop covering progressive supranuclear palsy, multiple system atrophy and cortico basal degeneration |
| 004776 |
D. A. Grimes [Canada] ; D. Bulman [Canada] ; P. St. George-Hyslop [Canada] ; A. E. Lang [Canada] | Inherited myoclonus‐dystonia: Evidence supporting genetic heterogeneity |
| 004807 |
Anthony E. Lang [Canada] | Essential palatal tremor |
| 004826 |
Y. R. Wu [Taïwan] ; R. Levy [Canada] ; P. Ashby [Canada] ; R. R. Tasker [Canada] ; J. O. Dostrovsky [Canada] | Does stimulation of the GPi control dyskinesia by activating inhibitory axons? |
| 004871 |
A. Jon Stoessl [Canada] | Assessing the integrity of the dopamine system in Parkinson's disease: How best to do it? |
| 004874 |
Neil R. Cashman [Canada] | Amyotrophic Lateral Sclerosis. Robert H. Brown, Jr., Vincent Meininger, and Michael Swash, eds. |
| 004877 |
Anette V. Nieves [Canada] ; Janis M. Miyasaki [Canada] ; Anthony E. Lang [Canada] | Acute onset dystonic camptocormia caused by lenticular lesions |
| 004885 |
Elan D. Louis [États-Unis] ; Livia Barnes [États-Unis] ; Kristin J. Wendt [États-Unis] ; Blair Ford [États-Unis] ; Maria Sangiorgio [États-Unis] ; Samer Tabbal [États-Unis] ; Linda Lewis [États-Unis] ; Petra Kaufmann [États-Unis] ; Carol Moskowitz [États-Unis] ; Cynthia L. Comella [États-Unis] ; Christopher C. Goetz [États-Unis] ; Anthony E. Lang [Canada] | A teaching videotape for the assessment of essential tremor |
| 004886 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Lee Cyn Ang [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche] | 69‐Year‐old man with gait disturbance and parkinsonism |
| 004896 |
Marie-Hélène Saint-Hilaire [États-Unis] ; Jean-Marc Saint-Hilaire [Canada] | Jumping frenchmen of Maine |
| 004969 |
Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique] | Risperidone in the treatment of dopamine‐induced psychosis in Parkinson's disease: An open pilot trial |
| 004974 |
Michael F. Mazurek [Canada] ; Patricia I. Rosebush [Canada] | Reply |
| 004A17 |
Jean A. Saint-Cyr [Canada] ; Lisa L. Trépanier [Canada] | Neuropsychologic assessment of patients for movement disorder surgery |
| 004A40 |
Ida Tonolli [France] ; Roselyne Aurenty [France] ; Robert George Lee [France, Canada] ; François Viallet [France] ; Jean Massion [France] | Lateral leg raising in patients with Parkinson's disease: Influence of equilibrium constraint |
| 004B20 |
Connie Marras [Canada] ; Annette V. Nieves [Canada] | Book reviews |
| 004B22 |
Jennifer Fine [Canada] | Book review |
| 004B38 |
Martin Michaud [Canada] ; Allal Chabli [Canada] ; Gilles Lavigne [Canada] ; Jacques Montplaisir [Canada] | Arm restlessness in patients with restless legs syndrome |
| 004B39 |
Eric A. Roy [Canada] | Apraxia in diseases of the basal ganglia |
| 004B48 |
Christopher Dromey [Canada] ; Rajeev Kumar [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] | An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice |
| 004B63 |
Brian M. Ross [Canada] ; Klaus Eder [Allemagne] ; Anna Moszczynska [Canada] ; Nikolaos Mamalias [Canada] ; Jacques Lamarche [Canada] ; Lee Ang [Canada] ; Massimo Pandolfo ; Guy Rouleau [Canada] ; Manfred Kirchgessner [Allemagne] ; Stephen J. Kish [Canada] | Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type‐1 |
| 004B78 |
Jean A. Saint-Cyr [Canada] ; Lisa L. Trepanier [Canada] | Neuropsychologic assessment of patients for movement disorder surgery |
| 004C30 |
Michael D. Hill [Canada] ; Rajeev Kumar [Canada] ; Andres Lozano [Canada] ; Charles H. Tator [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada] | Syringomyelic dystonia and athetosis |
| 004C44 |
Rajeev Kumar [Canada] ; Robert Chen [Canada] ; Peter Ashby [Canada] | Safety of transcranial magnetic stimulation in patients with implanted deep brain stimulators |
| 004D09 |
David A. Grimes [Canada] ; Catherine B. Bergeron [Canada] ; Anthony E. Lang [Canada] | Motor neuron disease‐inclusion dementia presenting as cortical‐basal ganglionic degeneration |
| 004D30 |
Takafumi Kato ; Jacques Y. Montplaisir ; Pierre J. Blanchet ; James P. Lund [Canada] ; Gilles J. Lavigne | Idiopathic myoclonus in the oromandibular region during sleep: A possible source of confusion in sleep bruxism diagnosis |
| 004D45 |
Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anthony E. Lang [Canada] ; Esther Cubo [États-Unis] | Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state |
| 004D49 |
Anthony S-I Pakiam [Canada] ; Anthony E. Lang [Canada] | Essential palatal tremor: Evidence of heterogeneity based on clinical features and response to sumatriptan |
| 004D57 |
Robert Chen [États-Unis, Canada] ; Barbara I. Karp [États-Unis] ; Susanne R. Goldstein [États-Unis] ; William Bara-Jimenez [États-Unis] ; Zaneb Yaseen [États-Unis] ; Mark Hallett [États-Unis] | Effect of muscle activity immediately after botulinum toxin injection for writer's cramp |
| 004D63 |
Jennifer Fine [Canada] ; Anthony E. Lang [Canada] | Dose‐induced penile erections in response to ropinirole therapy for Parkinson's disease |
| 004D64 |
Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Dopa‐responsive dystonia: Recent advances and remaining issues to be addressed |
| 004D90 |
Patricia I. Rosebush [Canada] ; Michael F. Mazurek [Canada] | Catatonia: Re‐awakening to a forgotten disorder |
| 004E00 |
Paul Sandor [Canada] | Book review |
| 004E01 |
Anthony E. Lang [Canada] | Book review |
| 004E14 |
Barbara Illowsky Karp [Canada] ; Susanne R. Goldstein [Canada] ; Robert Chen [Canada] ; Ali Samii [États-Unis] ; William Bara-Jimenez [Canada] ; Mark Hallett [Canada] | An open trial of clozapine for dystonia |
| 004E42 |
P. J. Bedard [Canada] ; P. J. Blanchet [Canada] ; D. Levesque [Canada] ; J.-J. Soghomonian [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; F. Calon [Canada] ; P. Falardeau [Canada] ; B. Gomez-Mancilla [Canada] ; J.-P. Doucet [Canada] ; G. S. Robertson [Canada] ; T. Dipaolo [Canada] | Pathophysiology of L-Dopa-induced dyskinesias |
| 004E57 |
B. I. Karp [États-Unis, Canada] ; S. R. Goldstein [États-Unis, Canada] ; R. Chen [États-Unis, Canada] ; A. Samii [États-Unis] ; W. Bara-Jimenez [États-Unis, Canada] ; M. Hallett [États-Unis, Canada] | An open trial of clozapine for dystonia |
| 004E89 |
André Parent [Canada] ; Francesca Cicchetti [Canada] | The current model of basal ganglia organization under scrutiny |
| 004F30 |
Seyed M. Mirsattari [Canada] ; Christopher Power [Canada] ; Nath [Canada, États-Unis] | Parkinsonism with HIV infection |
| 004F36 |
Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] | Pallidotomy for Tremor |
| 004F68 |
Ali H. Rajput [Canada] ; Alex Rajput [Canada] ; Anthony E. Lang [Canada] ; Rajeev Kumar [Canada] ; Ryan J. Uitti [États-Unis] ; David G. Le Couteur [Australie] ; Sally J. Mccann [Australie] ; Mark W. Becher [États-Unis] ; Christopher A. Ross [États-Unis] ; Richard Hardie [Royaume-Uni] | Letters to the Editor |
| 004F70 |
Alberto Albanese [Italie] ; Jonathan W. Mink [États-Unis] ; André Parent [Canada] ; Francesca Cicchetti [Canada] | Letters to the Editor |
| 004F71 |
David Riley [États-Unis] ; A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; S. Birdi [Canada] ; R. Macaulay [Canada] | Letter to the Editor |
| 004F79 |
Wayne Martin [Canada] ; Frank Q. Ye [Canada] ; Peter S. Allen [Canada] | Increasing striatal iron content associated with normal aging |
| 004F85 |
Jacques Montplaisir [Canada] ; Sylvie Boucher [Canada] ; Alain Nicolas [Canada] ; Paul Lesperance [Canada] ; Anik Gosselin [Canada] ; Pierre Rompré [Canada] ; Gilles Lavigne [Canada] | Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome |
| 005061 |
Klaus Eder [Allemagne] ; Stephen J. Kish [Canada] ; Manfred Kirchgessner [Allemagne] ; Ross [Canada] | Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type‐1 |
| 005130 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; A. E. Lang [Canada] | Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease |
| 005145 |
W. R. W. Martin [Canada] ; F. Q. Ye ; P. S. Allen | Increasing striatal iron content associated with normal aging |
| 005226 |
Anthony E. Lang [Canada] ; P. Martíanez-Martín [Espagne] ; D. García Urra [Espagne] ; J. Balseiro G Mez [Espagne] | Timed tests in parkinson's disease evaluation1 |
| 005239 |
Lobbezoo [Canada, Pays-Bas] ; Lavigne [Canada] ; R. Tanguay [Canada] ; J. Y. Montplaisir [Canada] | The effect of the catecholamine precursor L‐Dopa on sleep bruxism: A controlled clinical trial |
| 005272 |
A. Strafella [Canada] ; Ashby [Canada] ; A. E. Lang [Canada] | Reflex myoclonus in cortical‐basal ganglionic degeneration involves a transcortical pathway |
| 005296 |
A. H. Rajput [Canada] ; J. D. Mchattie [Canada] | Ophthalmoplegia and leg myorhythmia in Whipple's disease: Report of a case |
| 005309 |
Prochazka [Canada] ; David J. Bennett [Canada] ; Marilee J. Stephens [Canada] ; Susan K. Patrick [Canada] ; Rosemary Sears-Duru [Canada] ; Ted Roberts [Canada] ; Jack H. Jhamandas [Canada] | Measurement of rigidity in Parkinson's disease |
| 005322 |
Anthony Feinstein [Canada] ; C. M. Sue [Australie] ; J. G. L. Morris [Australie] ; John G. Nutt [États-Unis] ; Stephen T. Gancher [États-Unis] ; Anthony E. Lang [Canada] ; Tetsuo Ashizawa [États-Unis] ; Joseph Jankovic [États-Unis] | Letters to the editor |
| 005329 |
Rajput [Canada] ; M. E. Fenton [Canada] ; S. Birdi [Canada] ; R. Macaulay [Canada] | Is levodopa toxic to human substantia nigra? |
| 005331 |
Antonio Strafella [Canada] ; Ashby [Canada] ; Michael Munz [Canada] ; John O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Inhibition of voluntary activity by thalamic stimulation in humans: Relevance for the control of tremor |
| 005342 |
Lozano [Canada] ; R. Kumar [Canada] ; R. E. Gross [Canada] ; N. Giladi [Israël] ; W. D. Hutchison [Canada] ; J. O. Dostrovsky [Canada] ; Anthony E. Lang [Canada] | Globus pallidus internus pallidotomy for generalized dystonia |
| 005361 |
Alex Rajput [États-Unis] ; Asha Kishore ; B. Snow ; C. F. Bolton [Canada] ; Rajput [Canada] | Dopa‐responsive, nonprogressive, juvenile parkinsonism: Report of a case |
| 005375 |
Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; Alex Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada] | Concordance of common movement disorders among familial cases |
| 005380 |
Huang [Taïwan] ; Nai-Shin Chu [Taïwan] ; Chin-Song Lu [Taïwan] ; Donald B. Calne [Canada] | Cock gait in manganese intoxication |
| 005382 |
Montplaisir [Canada] ; Sylvie Boucher [Canada] ; Gaétan Poirier [Canada] ; Gilles Lavigne [Canada] ; Odile Lapierre [Canada] ; Paul Lespérance [Canada] | Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria |
| 005413 |
Singer [États-Unis] ; Anthony E. Lang [Canada] ; Oksana Suchowersky [Canada] | Adult‐onset subacute sclerosing panencephalitis: Case reports and review of the literature |
| 005421 |
John Maher [Canada] ; Rshujeel Choudhri [Canada] ; William Halliday [Canada] ; Christopher Power [Canada] ; Nath [Canada] | AIDS dementia complex with generalized myoclonus |
| 005446 |
E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The role of the immune system in neurodegenerative disorders |
| 005451 |
F. Lobbezoo [Canada] ; G. J. Lavigne [Canada] ; R. Tanguay [Canada] ; J. Y. Montplaisir [Canada] | The effect of the catecholamine precursor L-dopa on sleep bruxism : A controlled clinical trial |
| 005488 |
A. Prochazka [Canada] ; D. J. Bennett [Canada] ; M. J. Stephens [Canada] ; S. K. Patrick [Canada] ; R. Sears-Duru [Canada] ; T. Roberts [Canada] ; J. H. Jhamandas [Canada] | Measurement of rigidity in Parkinson's disease |
| 005494 |
A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; S. Birdi [Canada] ; R. Macaulay [Canada] | Is levodopa toxic to human substantia nigra? |
| 005500 |
A. M. Lozano [Canada] ; R. Kumar [Canada] ; R. E. Gross [Canada] ; N. Giladi [Israël] ; W. D. Hutchison [Canada] ; J. O. Dostrovsky [Canada] ; A. E. Lang [Canada] | Globus pallidus internus pallidotomy for generalized dystonia |
| 005517 |
A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; A. Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada] | Concordance of common movement disorders among familial cases |
| 005522 |
C.-C. Huang [Taïwan] ; N.-S. Chu [Taïwan] ; C.-S. Lu [Taïwan] ; D. B. Calne [Canada] | Cock gait in manganese intoxication |
| 005523 |
J. Montplaisir [Canada] ; S. Boucher [Canada] ; G. Poirier [Canada] ; G. Lavigne [Canada] ; O. Lapierre [Canada] ; P. Lesperance [Canada] | Clinical, polysomnographic, and genetic characteristics of restless legs syndrome : A study of 133 patients diagnosed with new standard criteria |
| 005543 |
C. Singer [États-Unis] ; A. E. Lang [Canada] ; O. Suchowersky [Canada] | Adult-onset subacute sclerosing panencephalitis : Case reports and review of the literature |
| 005555 |
Fahn [États-Unis] ; Mitchell F. Brin ; Andrew J. Dwork [États-Unis] ; William J. Weiner [États-Unis] ; Christopher G. Goetz [États-Unis] ; Ali H. Rajput [Canada] | What is it? case 1, 1996: Rapidly progressive parkinsonism, incontinence, impotency, and levodopa‐induced moaning in a patient with multiple myeloma |
| 005576 |
Francesca Cicchetti [Canada] ; Parent [Canada] | Striatal interneurons in Huntington's disease: Selective increase in the density of calretinin‐immunoreactive medium‐sized neurons |
| 005624 |
Elan D. Louis [États-Unis] ; Kenji Nakashima [Japon] ; Masayoshi Kusumi [Japon] ; Kazuro Takahashi [Japon] ; Yuichi Inoue [Japon] ; Ryan J. Uitti [États-Unis] ; J. Eric Ahlskog [États-Unis] ; D. M. Maraganore [États-Unis] ; Anthony E. Lang [Canada] | Letters to the editor |
| 005634 |
Paul J. Tuite [Canada] ; Carlos Navarette [Canada] ; Vera Bril [Canada] ; Anthony E. Lang [Canada] | Idiopathic generalized myokymia (Isaacs' syndrome) with hand posturing resembling dystonia |
| 005639 |
Valerie L. Soland [Canada] ; Kailash P. Bhatia [Royaume-Uni] ; Geoffrey L. Sheean [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Hereditary geniospasm: Two new families |
| 005663 |
Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 005665 |
P. J. Blanchet [Canada] ; R. Grondin [Canada] ; Bédard [Canada] | Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primates |
| 005669 |
Albert Gjedde [Canada] | DOPA Decarboxylase |
| 005682 |
V. Soland [Canada] ; F. Evoy [Canada] ; J. Rivest [Canada] | Cervical dystonia due to a frontal meningioma |
| 005689 |
Lucien Bettendorff [Belgique] ; Frank Mastrogiacomo [Canada] ; Jacques Lamarche [Canada] ; Slobodan Dioži [Yougoslavie] ; Kish [Canada] | Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1 |
| 005698 |
Frank Q. Ye [Canada] ; Peter S. Allen [Canada] ; Martin [Canada] | Basal ganglia iron content in Parkinson's disease measured with magnetic resonance |
| 005799 |
Anthony E. Lang [Canada] ; Mandar Jog [Canada] ; Peter Ashby [Canada] | “Weight‐holding tremor”: An unusual task‐specific form of essential tremor? |
| 005804 |
Lisa M. Shulman [États-Unis] ; Anthony E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; Noble J. David [États-Unis] ; Weiner [États-Unis] | What is it?. Case 1, 1995: Psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction |
| 005807 |
Walters ; Michael S. Aldrich [États-Unis] ; Richard Allen [États-Unis] ; Sonia Ancoli-Israel [États-Unis] ; David Buchholz [États-Unis] ; Sudhansu Chokroverty [États-Unis] ; Giorgio Coccagna [Italie] ; Christopher Earley [États-Unis] ; Bruce Ehrenberg [États-Unis] ; T. G. Feest [Royaume-Uni] ; Wayne Hening [États-Unis] ; Neil Kavey [États-Unis] ; Gilles Lavigne [Canada] ; Joseph Lipinski [États-Unis] ; Elio Lugaresi [Italie] ; Pasquale Montagna [Italie] ; Jacques Montplaisir [Canada] ; Sarah S. Mosko [États-Unis] ; Wolfgang Oertel [Allemagne] ; Daniel Picchietti [États-Unis] ; Thomas Pollm Cher [Allemagne] ; Renata Shafor [États-Unis] ; Robert C. Smith [États-Unis] ; Wenche Telstad [Norvège] ; Claudia Trenkwalder [Allemagne] ; Christian Von Scheele [Suède] ; Arthur S. Walters [États-Unis] ; J. Catesby Ware ; Marco Zucconi [Italie] | Toward a better definition of the restless legs syndrome |
| 005810 |
Caviness [États-Unis] ; Peter A. Forsyth [Canada] ; Donald D. Layton [États-Unis] ; Thomas J. Mcphee [États-Unis] | The movement disorders of adult opsoclonus |
| 005824 |
Xiao-Hui Zhong [Canada] ; John W. Haycock [États-Unis] ; Kathleen Shannak [Canada] ; Yves Robitaille [Canada] ; Jonathan Fratkin [États-Unis] ; Arnuf H. Koeppen [États-Unis] ; Oleh Hornykiewicz [Canada, Autriche] ; Kish [Canada] | Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy |
| 005825 |
Lenz [États-Unis] ; S. L. Normand [États-Unis] ; H. C. Kwan [Canada] ; D. Andrews [Canada] ; L. H. Rowland [États-Unis] ; M. W. Jones [États-Unis] ; M. Seike [États-Unis] ; Y. C. Lin [États-Unis] ; R. R. Tasker [Canada] ; J. O. Dostrovsky [Canada] ; Y. E. Lenz [États-Unis] | Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor |
| 005831 |
Duarte ; L. E. Clavería ; J. De Pedro-Cuesta [Espagne, Suède] ; A. P. Sempere ; F. Coria ; D. B. Calne [Canada] | Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity |
| 005881 |
Perminder Sachdev [Australie] ; Anthony E. Lang [Canada] | Letters to the editor |
| 005883 |
Anthony E. Lang [Canada] ; Alin-Louis Benabid [France] ; William C. Koller [États-Unis] ; Andres M. Lozano [Canada] ; Jose A. Obeso [Espagne] ; C. Warren Olanow [États-Unis] ; Pierre Pollak [France] ; M. Macucci [Italie] ; M. T. Dotti [Italie] ; A. Federico [Italie] | Letters to the editor |
| 005897 |
Lang [Canada] | Hemiatrophy, juvenile‐onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult‐onset hemiparkinsonism: The spectrum of hemiparkinsonism‐hemiatrophy syndrome |
| 005899 |
J. M. Wojcieszek [Canada] ; A. E. Lang [Canada] | Gestes antagonistes in the suppression of tics: “Tricks for tics” |
| 005920 |
Mandar S. Jog [Canada] ; Lang [Canada] | Chronic acquired hepatocerebral degeneration: Case reports and new insights |
| 005935 |
Suchowersky [Canada] ; Sarah Furtado [Canada] ; Gina Rohs [Canada] | Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease |
| 005957 |
Nahmias [Canada] ; Lindi Wahl [Canada] ; Raman Chirakal [Canada] ; Gunter Firnau [Canada] ; E. Stephen Garnett [Canada] | A probe for intracerebral aromatic amino‐acid decarboxylase activity: Distribution and kinetics of [18F]6‐fluoro‐L‐m‐tyrosine in the human brain |
| 005973 |
XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada] | Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy |
| 005A11 |
A. E. Lang [Canada] | Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism : the spectrum of hemiparkinsonism-hemiatrophy syndrome |
| 005A32 |
O. Suchowersky [Canada] ; S. Furtado ; G. Rohs | Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease |
| 005A43 |
C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. Garnett | A probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain |
| 005A61 |
Lang [Canada] | Withdrawal akathisia: Case reports and a proposed classification of chronic akathisia |
| 005A67 |
Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; H. M. Shale [États-Unis] ; A. E. Lang [Canada] ; D. A. Chernik [États-Unis] ; T. A. Chmura [États-Unis] ; J. E. Ahlskog [États-Unis] ; E. E. Dorflinger [États-Unis] | Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment |
| 005A88 |
Mendis [Canada] ; Erich Mohr [Canada] ; Amanda George [Canada] ; Ilene N. Rusk [Canada] ; Peggy Gray [Canada] ; J. David Grimes [Canada] | Symptomatic relief from treatment‐induced psychosis in Parkinson's disease: An open‐label pilot study with remoxipride |
| 005B01 |
Thomas R. Zimmerman Jr. [États-Unis] ; Jacob I. Sage [États-Unis] ; Anthony E. Lang [Canada] ; Mark [États-Unis] | Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment |
| 005B08 |
R. K. Mosewich [Canada] ; A. H. Rajput [Canada] ; A. Shuaib [Canada] ; B. Rozdilsky [Canada] ; L. Ang [Canada] | Pulmonary embolism: An under‐recognized yet frequent cause of death in parkinsonism |
| 005B21 |
Terry Curran [Canada] ; Lang [Canada] | Parkinsonian syndromes associated with hydrocephalus: Case reports, a review of the literature, and pathophysiological hypotheses |
| 005B56 |
Gilles Fénelon [France] ; Annaék Fève [France] ; Avindra Nath [Canada] ; Douglas E. Hobson [Canada] ; A. H. V. Schapira [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; M. S. Sandy [États-Unis] ; J. W. Langston [États-Unis] ; D. A. Di Monte [États-Unis] ; James J. Gaul [États-Unis] | Letters to the editor |
| 005B64 |
Andermann [Canada] ; Shunsuke Ohtahara [Japon] ; Eva Andermann [Canada] ; Peter Camfield [Canada] ; Katsuhiro Kobayashi [Japon] | Infantile hypotonia and paroxysmal dystonia: A variant of alternating hemiplegia of childhood? |
| 005C06 |
Jonne Wojcieszek [Canada] ; Lang [Canada] ; Joseph Jankovic [États-Unis] ; Paul Greene [États-Unis] ; John Deck [Canada] | Case 1, 1994: Rapidly progressive aphasia, apraxia, dementia, myoclonus, and parkinsonism |
| 005C31 |
Olanow [États-Unis] ; S. Fahn [États-Unis] ; M. Muenter [États-Unis] ; H. Klawans [États-Unis] ; H. Hurtig [États-Unis] ; M. Stern [États-Unis] ; I. Shoulson [États-Unis] ; R. Kurlan [États-Unis] ; J. D. Grimes [Canada] ; Joseph Jankovic [États-Unis] ; M. Hoehn [États-Unis] ; C. H. Markham [États-Unis] ; R. Duvisin [États-Unis] ; O. Reinmuth [États-Unis] ; H. A. Leonard [États-Unis] ; E. Ahlskog [États-Unis] ; R. Feldman [États-Unis] ; L. Hershey [États-Unis] ; M. D. Yahr [États-Unis] | A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease |
| 005C34 |
A. E. Lang [Canada] | Withdrawal akathisia: case reports and a proposed classification of chronic akathisia |
| 005C35 |
J. Wojcieszek [Canada] ; A. E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; P. Greene ; J. Deck | What is it? Case 1, 1994: rapidly progressive aphasia, apraxia, dementia, myoclonus, and Parkinsonism |
| 005C45 |
T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. Grimes | Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride |
| 005C71 |
F. Andermann [Canada] ; S. Ohtahara ; E. Andermann [Canada] ; P. Camfield ; K. Kobayashi | Infantile hypotonia and paroxysmal dystonia: a variant of alternating hemiplegia of childhood? |
| 005D16 |
Stoessl [Canada] ; Elizabeth Polanski [Canada] ; Hanna Frydryszak [Canada] | The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia |
| 005D33 |
Tatton [Canada] | Selegiline can mediate neuronal rescue rather than neuronal protection |
| 005D65 |
Nath [Canada] ; Douglas E. Hobson [Canada] ; Anne Russel [Canada] | Movement disorders with cerebral toxoplasmosis and AIDS |
| 005D97 |
Baltazar Gomez-Mancilla [Canada, Suisse] ; René Boucher [Canada, Suisse] ; Céline Gagnon [Canada, Suisse] ; Thérèse Di Paolo [Canada, Suisse] ; Rudolf Markstein [Canada, Suisse] ; Bédard [Canada, Suisse] | Effect of adding the D1 agonist CY 208–243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors |
| 005E28 |
M. Guttman [Canada] ; G. Léger [Canada] ; A. Reches [Israël] ; A. Evans [Canada] ; H. Kuwabara [Canada] ; J. M. Cedarbaum [États-Unis] ; Gjedde [Canada] | Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa |
| 005E42 |
A. J. Stoessl [Canada] ; E. Polanski ; H. Frydryszak | The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia |
| 005E53 |
W. G. Tatton [Canada] | Selegiline can mediate neuronal rescue rather than neuronal protection |
| 005E74 |
A. Nath [Canada] ; D. E. Hobson [Canada] ; A. Russell | Movement disorders with cerebral toxoplasmosis and AIDS |
| 005E85 |
B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard | Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors |
| 005F13 |
Russman [États-Unis] ; Anthony E. Lang [Canada] ; Stanley Fahn [États-Unis] ; Paul Greene [États-Unis] ; Margaret L. Grunnet [États-Unis] | What is it? Case 1, 1992: Progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girl |
| 006001 |
Robert E. Burke [États-Unis] ; N. A. Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; S. Moghal [Canada] ; A. H. Rajput [Canada] ; Andrew J. Hughes [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. W. Thickbroom ; F. L. Mastaglia ; J. Artieda [Espagne] ; J. A. Obeso [Espagne] ; R. J. Hardie [Royaume-Uni] ; R. A. Morgan-Hughes [Royaume-Uni] | Letters to the Editor |
| 006023 |
E. Pourcher [Canada] ; B. Gomez-Mancilla [Canada] ; Bédard [Canada] | Ethosuximide and tremor in Parkinson's disease: A pilot study |
| 006026 |
Baltazar Gomez-Mancilla [Canada] ; Jean-François Latulippe [Canada] ; René Boucher [Canada] ; Bédard [Canada] | Effect of ethosuximide on rest tremor in the MPTP monkey model |
| 006029 |
Baltazar Gomez-Mancilla [Canada] ; René Boucher [Canada] ; Bédard [Canada] | Effect of LY 171555 and CY 208‐243 on tremor suppression in the MPTP monkey model of parkinsonism |
| 006037 |
J. M. Palacios ; G. Mengod ; B. Landwehrmeyer ; B. O'Dowd [Canada] ; A. Probst | Dopamine receptors: Molecular biology, pharmacology, neuroanatomy and alterations in movement disorders |
| 006098 |
B. Gomez-Mancilla [Canada] ; J.-F. Latulippe ; R. Boucher ; P. J. Bedard | Effect of ethosuximide on rest tremor in the MPTP monkey model |
| 006099 |
B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard | Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism |
| 006190 |
Lang [Canada] ; Kapil D. Sethi [États-Unis] ; John P. Provias [Canada] ; John H. Deck [Canada] | Case 1, 1991: A severe and fatal systemic illness first presenting with a movement disorder |
| 006210 |
A. E. Lang [Canada] ; K. D. Sethi ; J. P. Provias ; J. H. Deck | What is it? Case 1, 1991 : a severe and fatal systemic illness first presenting with a movement disorder |
| 006263 |
Paul E. Greene [États-Unis] ; Stanley Fahn [États-Unis] ; Anthony E. Lang [Canada] ; Ray L. Watts [États-Unis] ; David Eidelberg [États-Unis] ; James M. Powers [États-Unis] | Waht is it? Case 1, 1990: Progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb |
| 006278 |
Ranjit Ranawaya [Canada] ; David Riley [Canada] ; Lang [Canada] | Psychogenic dyskinesias in patients with organic movement disorders |
| 006289 |
Shandling [Canada] ; P. L. Carlen [Canada] ; A. E. Lang [Canada] | Parkinsonism in alcohol withdrawal: A follow‐up study |
| 006292 |
Mohit Bhatt [Canada] ; Barry Snow [Canada] ; Michael Varelas [Canada] ; Donald Calne [Canada] | Palatal myoclonus: Treatment with 5‐hydroxytryptophan and carbidopa |
| 006308 |
G. A. M. Verheul [Pays-Bas] ; C. C. Tyssen [Pays-Bas] ; Stewart A. Factor [États-Unis] ; Anthony E. Lang [Canada] ; Niall Quinn [Royaume-Uni] ; Richard Hardie [Royaume-Uni] ; Un Jung Kang [États-Unis] ; Stanley Fahn [Pays-Bas, États-Unis, Canada, Royaume-Uni] | Letters to the editor |
| 006319 |
Lawrence W. Svenson [Canada] | Geographic distribution of deaths due to Parkinson's disease in canada: 1979–1986 |
| 006324 |
Dietz [États-Unis] ; Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [Canada] | Evaluation of a modified inverted walking stick as a treatment for Parkinsonian freezing episodes |
| 006331 |
Lewis [Canada] ; M. J. Gawel [Canada] | Diffuse lewy body disease with dementia and oculomotor dysfunction |
| 006352 |
Mohit Bhatt [Canada] ; Erik Wolters [Canada] ; Joseph Tsui [Canada] ; Barry J. Snow [Canada] ; Calne [Canada] | A case of rabies in North America |
| 006408 |
W R Martin [Canada] | Imaging techniques in Parkinson's disease. |
| 006425 |
Andermann [Canada] ; Samuel Berkovic [Canada] ; Stirling Carpenter [Canada] ; Eva Andermann [Canada] | The Ramsay Hunt syndrome is no longer a useful diagnostic category |
| 006438 |
Koller [États-Unis] ; George F. Wong [États-Unis] ; Anthony Lang [Canada] | Posttraumatic movement disorders: A review |
| 006452 |
Martin [Canada] | Imaging techniques in Parkinson's disease |
| 006464 |
Donald B. Calne [Canada] | Current concepts on the etiology of Parkinson's disease |
| 006519 |
Heidi Shale [États-Unis] ; Stanley Fahn [États-Unis] ; Donald B. Calne [Canada] | What is it? Case 1, 1988. Head tilt in a young girl associated with neck pain and limitation of neck movement |
| 006544 |
David Riley [Canada] ; Lang [Canada] | Hemiballism in multiple sclerosis |
| 006600 |
Anthony E. Lang [Canada] | Sudden confusion with levodopa withdrawal |
| 006603 |
M. Guttman [Canada] ; Lang [Canada] ; E. S. Garnett [Canada] ; C. Nahmias [Canada] ; G. Firnau [Canada] ; F. J. Tyndel [Canada] ; A. S. Gordon [Canada] | Regional cerebral glucose metabolism in SLE chorea: Further evidence that striatal hypometabolism is not a correlate of chorea |
| 006680 |
A. E. Lang [Canada] ; A. Birnbaum [Canada] ; R. D. G. Blair [Canada] ; C. Kierans [Canada] | Levodopa dose‐related fluctuations in presumed olivopontocerebellar atrophy |
| 006688 |
Calne [Canada] ; Urpo K. Rinne [Finlande] | Controversies in the management of Parkinson's disease |
| 006691 |
Oksana Suchowersky [Canada] ; Hayden [Canada] ; W. R. Wayne Martin [Canada] ; A. Jon Stoessl [Canada] ; Anne M. Hildebrand [Canada] ; Brian D. Pate [Canada] | Cerebral metabolism of glucose in benign hereditary chorea |
